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1. INTRODUCTION 
In recent decades there has been considerable debate on inguinal hernias – 
etiology of the disease, indications for surgery, selection of the surgical 
approach and technique, selection of the prosthetic material and reduction of 
recurrences and chronic posthernioplasty symptoms. 
Although the well known and by far the most widely used mesh material 
polypropylene was developed 60 years ago [Coda et al., 2012; Earle and Mark, 
2008] and more than 160 different meshes for hernia repair are in the market 
[Coda et al., 2012], with millions of prosthetic meshes used worldwide each 
year [Bay-Nielsen et al., 2001a; Weyhe et al., 2007], we do not yet know the 
parameters of an ideal mesh [Simons et al., 2009]. 
After the widely used alloplasty in inguinal hernia surgery, the most 
common complication is chronic pain whose rates reach 51.6 % [O'Dwyer et al., 
2005]. The rate of foreign body feeling occurs in up to 43.8 % of patients after 
inguinal hernia repair [Post et al., 2004]. 
Considering the high rate of chronic pain and foreign body feeling after 
inguinal hernioplasty, which can have major influence on the patients’ quality 
of life, as well as serious socio-economic impacts, different mesh characteristics 
should be studied in order to identify the mesh whose usage results in lower 
rates of long-term pain and foreign body feeling. 
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2. REVIEW OF THE LITERATURE 
2.1. Definition of inguinal hernia 
The musculo-aponeurotic layer of the abdominal wall is formed in order to 
retain the organs of the abdominal cavity. However, there are some limited 
areas, including the groin region, where the anatomical structures are often defi-
cient resulting in hernia development.  
Inguinal hernia is defined as a protrusion of the contents of the abdominal 
cavity or preperitoneal fat through the hernia defect in the inguinal region 
[Simons et al., 2009] (Figure 1). 
Inguinal hernias can be direct or indirect, depending on their relationship to 
the inferior epigastric vessels. Direct or medial hernias occur medial to the 
inferior epigastric vessels and indirect hernias protrude lateral to the inferior 
epigastric vessels. There can also exist a combination of direct and indirect 





Figure 1. Groin anatomy during the anterior inguinal hernioplasty approach [Ferzli et 
al., 2008] (Reproduced with the permission of Elsevier) 
11 
2.2. Etiology of inguinal hernia 
The fundamental mechanism of formation of abdominal wall hernia is the loss 
of structural integrity at the musculo-aponeurotic layer [Franz, 2008].  
The cause of hernia formation is multifactorial, but many studies have identified 
pathological changes in collagen, resulting in development of a hernia [Bendavid, 
2004]. Also in a systematic review of Henriksen et al. hernia formation is 
associated with a decreased type I:III collagen ratio [Henriksen et al., 2011].  
According to the European Hernia Society (EHS) guidelines on the treat-
ment of inguinal hernia, smokers, patients with positive family hernia history, 
patent processus vaginalis, collagen disease, after an open appendectomy and 
prostatectomy, with ascites, on peritoneal dialysis, after long-term hard work or 
with chronic obstructive pulmonary disease have an increased risk of inguinal 
hernia development [Simons et al., 2009].  
 
 
2.3. Frequency of inguinal hernia 
Inguinal hernioplasty is one of the most common operations in general surgery. 
The incidence and prevalence of inguinal hernia is not exactly known [Rutkow, 
1998]. Inguinal hernias are more common in males than females (8–20:1) 
[Kingsnorth and Leblanc, 2003]. The lifetime risk for inguinal hernia operation 
is estimated to be 27 % in men and 3 % in women [Primatesta and Goldacre, 
1996].   
The rates of inguinal hernia repair (primary and recurrent hernias) in Estonia 
have been stable in the last decade (Figure 2). In 2012, there were 148 inguinal 
hernia repairs per 100,000 inhabitants in Estonia [TAI, 2012].  
 
 
Figure 2. Number of inguinal hernia operations per 100 000 inhabitants in 2003–2012 
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2.4. Diagnostics of inguinal hernia 
Patients with symptomatic inguinal hernias report a lump in the groin region, 
which might disappear in the supine position and they also have complaints 
about pain and discomfort in the groin, which are usually related to physical 
exercise and effort.  
However, inguinal hernias can also be asymptomatic. In a study of Gallegos 
et al. the cumulative probability of strangulation of inguinal hernias after 3 
months was 2.8 %, rising to 4.5 % after 2 years [Gallegos et al., 1991]. Con-
sidering the low risk of strangulation of inguinal hernias, watchful waiting is 
considered an acceptable and safe option in asymptomatic inguinal hernias 
[Simons et al., 2009]. However, we have to consider the fact that in more than 
70 % of cases patients will cross over from the group of watchful waiting to the 
group of surgical treatment because of development of symptoms [Miserez et 
al., 2014].  
Acute complications of inguinal hernias beyond the scope of this thesis. 
In most cases the diagnosis of inguinal hernia is based on physical exami-
nation and other investigations are usually not needed. According to Kraft et al., 
the sensitivity of preoperative examination is 92 % and specificity 93 % [Kraft 
et al., 2003]. In case of unclear diagnosis, ultrasound is recommended. If ultra-
sound is negative, then MRI with Valsalva should be performed [Simons et al., 
2009] (Figure 3a, 3b). 
Differentiating between a direct and an indirect hernia preoperatively is not 
necessary, but it is important to distinguish a femoral hernia from an inguinal 
hernia because of the high risk of incarceration in the former case [Simons et 
al., 2009].  
 
 
Figure 3a Figure 3b 
 
Figure 3a, 3b MRI of a 67-year old male patient with right-sided inguinal hernia 
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2.5. Treatment of inguinal hernia 
Hernias can be repaired only by surgical means. Many different types of in-
guinal hernia repairs have been described in history. Inguinal hernias can be 
repaired via an open or a laparoscopic approach. However, a consensus opinion 
regarding which method is the most advantageous has not been reached and the 
method used is often based on surgeon’s preference [Sanders and Waydia, 
2014].  
In the case of open inguinal hernia repair, tissue-based repairs or prosthetic 
repairs can be performed. Probably the best known tissue repairs are the Bassini 
technique and the Shouldice repair.  
Bassini reported his series of open tissue repairs in 1885 [Matthews and 
Neumayer, 2008]. The Bassini technique is based on repair of the posterior wall 
of the inguinal canal with interrupted non-absorbable sutures [Wantz, 1989].  
The Shouldice repair, originally described in 1953, is based on the Bassini 
repair, but uses several layers of running non-absorbable sutures [Simons et al., 
2009; Welsh and Alexander, 1993]. The Shouldice repair is considered to be the 
best conventional technique [Simons et al., 2009; Simons et al., 1996], but in 
general practice it results in high recurrence rates up to 15 % [Beets et al., 
1997].  
The more widespread laparoscopic approaches are transabdominal preperito-
neal (TAPP) repair and totally extraperitoneal (TEP) repair. In TAPP repair the 
mesh is placed into a preperitoneal position from the peritoneal cavity. In TEP 
repair the hernia is approached in the preperitoneal space and the peritoneum is 
not opened [Matthews and Neumayer, 2008]. 
According to the EHS guidelines on the treatment of inguinal hernia, the 
Lichtenstein and endoscopic inguinal hernia techniques are recommended as the 
best evidence-based options for primary inguinal hernia repair [Miserez et al., 
2014; Simons et al., 2009]. 
 
 
2.5.1. Lichtenstein technique 
Lichtenstein was a pioneer in the use of mesh in open inguinal hernia repair and 
his technique has become the gold standard of open inguinal hernia repair 
[Simons et al., 2009]. Lichtenstein had a theory that tissue–based repairs create 
tension in tissues and increase the likelihood of hernia recurrence [Lichtenstein 
et al., 1989].  
In the Lichtenstein technique a 5–6 cm skin incision is made, which starts 
from the pubic tubercule and extends laterally within the Langer’s lines [Amid, 
2004a].  
The external oblique aponeurosis is opened. The lower leaf of the external 
aponeurosis is freed from the spermatic cord and the upper leaf is freed from the 
underlying internal oblique muscle and aponeurosis for a distance of 3–4 cm 
above the inguinal floor. The iliohypogastric nerve is visualized. The spermatic 
cord with its cremaster covering is separated from the inguinal floor of the 
14 
inguinal canal and the pubic bone for a distance of about 2 cm beyond the pubic 
tubercle. When lifting the cord, the ilioinguinal nerve, the external spermatic 
vessels and the genital nerve should be included [Amid, 2004a].  
To explore the internal ring for indirect hernia sacs, the cremasteric sheath is 
incised longitudinally at the deep ring. Complete stripping and excision of the 
cremasteric fibers is unnecessary and can result in injury to the nerves, small 
blood vessels and vas deferens. Indirect hernia sacs are freed from the cord to a 
point beyond the neck of the sac and inverted without ligation. To minimize the 
risk of postoperative ischemic orchitis, complete non sliding scrotal hernia sacs 
are transected at the midpoint of the canal, leaving the distal section in place. 
The anterior wall of the distal sac is incised to prevent postoperative hydrocele 
formation. In large direct hernias the sac is inverted with an absorbable suture 
[Amid, 2004a].  
A 7 x 15 cm mesh is used. With the cord retracted cephalad, the lower 
medial corner of the mesh is placed over pubic tubercle, overlapping the pubic 
tubercle by 1.5–2 cm. The medial corner of the mesh is sutured to the rectus 
sheath above the pubic bone, avoiding the periosteum of the bone. This suture is 
continued as a continuous suture with no more than 3–4 passes to attach the 
lower edge of the mesh to the inguinal ligament up to a point just lateral to the 
internal ring. This prevents folding and movement of the mesh in the mobile 
area of the groin. A slit is made at the lateral end of the mesh, creating two tails 
(two-thirds wide above and one-third wide below). The cord is positioned 
between the two tails of the mesh. With the cord retracted downward and the 
upper leaf of the external oblique aponeurosis retracted upward, the upper edge 
of the mesh is sutured in place with two interrupted sutures (one suture to the 
rectus sheath and the other to the internal oblique aponeurosis, just lateral to the 
internal ring). While the mesh is fixed in place, it is important to give the mesh 
a dome-shape configuration. The tails of the mesh should be sutured with 
crossing the tails with a single non-absorbable monofilament suture, which 
creates a new internal ring made of mesh. The excess mesh on the lateral side is 
trimmed, leaving at least 5–6 cm of mesh lateral to the internal ring and it is 
placed underneath the external oblique aponeurosis [Amid, 2004a] (Figure 4).  
The external oblique aponeurosis is closed over the cord with an absorbable 





Figure 4. Extension of the mesh beyond the inguinal floor (dotted line) and the dome-




2.5.2. Lichtenstein versus laparoscopic repair 
The Working Group of EHS guideline performed a meta-analysis of studies 
comparing the Lichtenstein technique and endoscopic inguinal hernia repair 
(TEP/TAPP). The results of long-term recurrence rates were lower in the 
Lichtenstein group, but were insignificant after excluding the data of one 
surgeon in a study of Eklund et al. [Eklund et al., 2009; Miserez et al., 2014]. In 
the study of Eklund et al. one surgeon was responsible for 33 % of recurrences 
in the endoscopic repair group [Eklund et al., 2009].  
Also chronic pain was evaluated in above mentioned meta-analysis and the 
results of severe chronic pain did not differ between the open and the laparo-
scopic mesh repair groups [Miserez et al., 2014].  
It is well known that endoscopic inguinal hernia repair results in lower rate 
of wound complications but there can be, although infrequently, more serious 
complications (vascular and visceral injuries) after endoscopic repair [McCor-
mack et al., 2005; Paajanen et al., 2010].  
Although the learning curve of surgical operations is surgeon specific, the 
learning curve of endoscopic inguinal hernia repair has been estimated at 50–
100 cases [Matthews and Neumayer, 2008; Simons et al., 2009], with the first 
30–50 being the most critical [Simons et al., 2009]. In the study of Eklund et al. 
the learning curve was estimated to be 25 TEP operations, resulting in a 
situation that one surgeon was responsible for 33 % of recurrences in the laparo-
scopic group [Eklund et al., 2009]. Also in the update of EHS guideline on the 
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treatment of inguinal hernia it is stressed that endoscopic hernia repair, 
especially TEP, has a long learning curve [Miserez et al., 2014]. 
The learning curve of the Lichtenstein repair has not been evaluated in many 
studies, but in a study of Wiese et al. the Lichtenstein repair has been estimated 
as a safe and effective operation to be performed under supervision even by 
junior residents [Wiese et al., 2010]. Also in a study of Paajanen, which 
evaluated the results of the Lichtenstein repair done by senior consultants and 
surgical trainees, there was no difference in the long-term outcome and the 
learning curve was estimated to be relatively short [Paajanen, 2003; Paajanen 
and Varjo, 2010]. 
 
 
2.6. Classification of inguinal hernias 
There have been developed many different inguinal hernia classifications. Use 
of classifications is important for the description of the groin anatomy and the 
type of hernia. Also use of a general classification enables to analyse research 
data.  
According to the EHS guideline on the treatment of inguinal hernia, it is 
advisable to use the EHS classification [Simons et al., 2009]. In the EHS classi-
fication the size of the hernia orifice is registered as 1 (1 finger or  
<1.5 cm), 2 (2 fingers or <3 cm) and 3 (more than two fingers or >3 cm). 
Anatomic localisation is registered as L (lateral or indirect hernia), M (medial or 
direct hernia), F (femoral hernia). For a combined hernia, it is recommended to 
note the different hernias. Letter P or R should be used for a primary or re-
current hernia, respectively [Miserez et al., 2007].  
 
 
2.7. Meshes used for hernia repair 
If we could artificially produce tissues of the density and toughness of fascia and 
tendon, the secret of the radical cure of hernia would be discovered.  
Theodore Billroth (1829–1894) [Earle and Mark, 2008] 
 
In 1935 nylon (trade name Polyamid) was discovered and the first hernia 
prosthetics were produced. The first reports in which nylon was used as a 
prosthetic are from 1944 and 1948. In 1941 polyethylene terephthalate (trade 
name Dacron) was patented. In 1954 polypropylene was discovered and the 
chemists Natta and Ziegler won in 1961 the Nobel Prize in Chemistry [Coda et 
al., 2012]. Usher reported the use of polyethylene mesh (trade name Marlex) in 
incisional hernia repair in 1958 [Bringman et al., 2010]. For years surgeons 
could choose from among a few prosthetics until in the 1990s companies began 
producing many different kinds of products which were mostly produced from 
polypropylene [Coda et al., 2012].  
According to Coda et al., there are more than 160 meshes available on the 
market [Coda et al., 2012], making it complicated to choose a mesh whose 
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usage would result in the best outcome. There are meshes with 2D and 3D 
structures, flat meshes and plugs, monofilaments and multifilaments, absorbable 
and non-absorbable, with pores and without pores, with surface coating and 
combinations of these [Klinge and Klosterhalfen, 2012]. Despite the wide 
selection of brands available, nearly all meshes use one of the three basic mate-
rials – polypropylene, polyester or expanded polytetrafluoroethylene (ePTFE). 
These are used in combination with each other or with a range of additional 
materials [Brown and Finch, 2010].  
It was assumed that mesh was a material which could be used for abdominal 
wall reinforcement with formation of scar tissue. Earlier it was expected that the 
best meshes would be those made of very strong material and able to induce the 
most of fibrosis. However strong fibrotic reaction led to pain and movement 
restriction [Brown and Finch, 2010].  
Today an ideal mesh should be cost-effective, have no adhesion potential, 
have excellent tissue integration, minimal shrinkage, good memory and be easy 
to use. Ideal meshes should not promote infection, fistula or seroma formation 
and should not limit or negatively affect patient’s normal activity [Bringman et 
al., 2010]. The requirements for an ideal mesh in hernia surgery are known, but 
mesh that satisfies all requirements has not yet been found [Conze et al., 2008]. 
Each product has its own unique advantages and disadvantages and therefore 
one product might never address the wide spectrum of inguinal hernia disease 
[Cavazzola and Rosen, 2013].  
Soon after companies started to produce many different prosthetics, the 
weight of meshes became the most widely discussed topic in hernia surgery and 
the goal of all mesh developers was to produce lighter meshes in order to im-
prove biocompatibility [Weyhe et al., 2007]. Implants were classified according 
to the weight of the material in grams per square metre [Weyhe et al., 2007]. 
Differences in weight vary and in a study of Klinge and Klosterhalfen the 
weight of available meshes ranged between 11 and 130 g/m² [Klinge and 
Klosterhalfen, 2012]. However, there is no general definition for „lightweight“ 
and „heavyweight“. Nowadays the term „lightweight“ is used to describe a pro-
duct with larger pores resulting in a smaller surface area [Bringman et al., 
2010].  
Heavyweight meshes are designed with thick polymer fibres, smaller pores, 
high tensile strength and large surface area [Klosterhalfen et al., 2005]. The 
mean distension of the anterior abdominal wall at 16 N is in the range between 
11 % and 32 % for all directions [Junge et al., 2001]. Textile analysis of 
heavyweight meshes revealed an elasticity of 4–16 % at 16 N [Klosterhalfen et 
al., 2005]. Lighweight meshes were found to be superior due to their increased 
flexibility and reduction in discomfort [Brown and Finch, 2010]. After the 
introduction of lightweight meshes there was concern about their lower tensile 
strength. However, the tensile strength of surgical meshes in large incisional 
hernias, where the fascia cannot be closed and the bridging technique is used, is 
theoretically 32 N/cm at a maximum. In the case of abdominal wall aug-
mentation in small hernias, the tensile strength of the mesh is 16 N/cm 
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[Klosterhalfen et al., 2005]. Therefore, tensile strength of heavyweight meshes 
more than 100 N/cm is disproportional and leads to low flexibility of the ab-
dominal wall [Klosterhalfen et al., 2005; Welty et al., 2001].  
Klinge and Klosterhalfen have classified the meshes used for hernia repair, 
based mainly on porosity (Table 1). The aim of this classification is to group the 
different meshes so that the impact of material can be evaluated systematically 
from the data of studies and registries [Klinge and Klosterhalfen, 2012].  
Weyhe et al. reported in their experimental study that the main determinant 
of biocompatibility was the pore size of mesh rather than the amount implanted 
[Weyhe et al., 2006]. The inflammatory intensity of foreign body reaction 
depends on the porosity of meshes [Klinge et al., 2002b; Muhl et al., 2008]. As 
reported by Klinge et al., increased pore size had a major impact on the 
biological response [Klinge et al., 2002b]. In the case of small pores a dense 
scar plate will develop around the entire mesh [Klinge et al., 2002b; Muhl et al., 
2008] and the extent of foreign body reaction does not permit the ingrowth of 
the local tissue [Klinge et al., 2002b]. Larger pores are filled with the local fat 
tissue and a thin scar network will form, resulting in the proper elasticity of the 
implant (Figure 5) [Klinge et al., 2002b; Muhl et al., 2008]. If a mesh with large 
pores is used then large pores will guarantee preserving of elasticity and will 
hamper the bridging of inflammation across the pores [Klinge et al., 2002b]. 
The porosity of meshes is measured as the percentage of the area of the 
mesh, which is not covered by filaments, reflected as textile porosity. Effective 
porosity represents the area of the „good pores“ where bridging of the scar 
tissue is avoided by a sufficient interfilamentary distance. [Klinge and 
Klosterhalfen, 2012; Muhl et al., 2008]. Porosity decreases if foreign body 
reaction is considered [Muhl et al., 2008]. For polypropylene meshes, 1000 μm 
is the least distance that prevents bridging of the scar tissue, which then fills out 
the entire pore [Conze et al., 2008].  
While one possible reason for development of groin pain is non-absorbable 
sutures which are used for fixation of the mesh in Lichtenstein hernioplasty, 
other fixation solutions, among them self-gripping meshes, have been deve-
loped to reduce the rate of chronic pain. Self-gripping meshes have microgrips 
across mesh surface area, which ensure gripping between muscle fibres and the 
connective tissue and therefore no fixating sutures are needed [Chastan, 2009].  
An important feature to be emphasized is shrinkage of meshes. The mesh 
itself does not shrink, but the surface is reduced due to reduction in the fibrotic 
scar tissues surronding the mesh. Shrinkage must be taken into consideration in 




Table 1. Classification of meshes used for hernia repair [Klinge and Klosterhalfen, 2012] 
 
Class Description of class 
Class I Large pore meshes 
Ia monofilament 
Ib multifilament 
Ic mixed structure or polymer 
 
 Textile porosity >60 % 
 Effective porosity >0% 
Class II Small pore meshes 
Ia monofilament 
Ib multifilament 
Ic mixed structure or polymer 
 
 Textile porosity <60% 
 Without any effective 
porosity 
Class III Meshes with special features 
 
E. g. meshes with barrier function for 
intraperitoneal use 
Class IV Meshes with films 
 
Film-like meshes without porosity or 
submicronic pore size or secondarily 
excised pores 
Class V 3D meshes 
 
Pre-shaped, pre-formed, 3D devices 








Figure 5. A monofilament polypropylene mesh after incorporation with typical granu-
loma formation of inflammatory cells and fibrotic capsule (line) around the filament (1) 
and bridging scar tissue within the pore (arrow) (light microscopy, staining with 
haematoxylin and eosin, standard measure 200 μm) [Muhl et al., 2008] (Reproduced 
with the permission of John Wiley and Sons) 
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2.8. Hernia recurrence 
In the earlier period when tissue-based repairs were performed, the most widely 
discussed complication of hernia surgery was recurrence rate. Although some 
studies have reported low recurrence rates of tissue-based repairs (Shouldice 
repair) [Glassow, 1986; Paul et al., 1994], others have not obtained similar 
results [Beets et al., 1997; van Veen et al., 2007].  
Tension-free mesh repair has become the gold standard because of lower 
recurrence rates compared with conventional suturing techniques. According to 
literature data, recurrence rates after non-mesh repairs vary between 4.4 and  
17 % [Grant, 2000; van Veen et al., 2007]. Recurrence rates for mesh repairs 
vary between 0.3 and 2.2 % [Grant, 2000; van Veen et al., 2007].  
In a study of van Veen et al. half of the recurrences occurred more than  
3 years after operation, which made the authors speculate that in many studies 
recurrence rates were underestimated because of the lack of long-term follow-
up [van Veen et al., 2007].  
 
 
2.9. Chronic pain after inguinal hernia repair 
After the widespread use of mesh repairs the recurrence rates after inguinal 
hernia surgery have become acceptable and attention has been focused, instead 
of recurrence rates, on chronic pain.  
Although we can control pain with analgesics, chronic postsurgical pain is a 
major clinical problem, which can significantly influence patient’s quality of 
life. The rate of chronic pain after inguinal hernia mesh repair may occur in  
51.6 % of patients [O'Dwyer et al., 2005]. 
Pain is defined by the International Association for the Study of Pain (IASP) 
as an unpleasant sensory and emotional experience associated with actual or 
potential tissue damage or described in terms of such damage [Merskey and 
Bogduk, 1994].  
Distinction between acute  and chronic pain is usually based on time. Acute 
pain is characteristic of all hernia operations. Benzon et al. defined chronic pain 
as the pain that persists beyond the course of an acute disease or a reasonable 
time for an injury to heal, or that is associated with a chronic pathologic process 
that causes continuous pain, or the pain recurs at intervals of months or years 
[Benzon et al., 2011]. IASP has defined chronic pain as the pain lasting longer 
than 3 months [Merskey and Bogduk, 1994]. According to Aasvang and Kehlet, 
the usage of synthetic materials for hernia repair may lengthen the inflammatory 
response and therefore chronic pain is defined as the pain lasting ≥6 months 
[Aasvang and Kehlet, 2005]. A similar definition can also be found in a 
guideline published by Alfieri et al. [Alfieri et al., 2011].  
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2.9.1. Causes of chronic pain  
The reasons for posthernioplasty chronic pain are often unclear. It has been 
linked to nerve injury and nerve entrapment, but there is also association 
between the rate of chronic pain and the type of mesh used for hernia repair.  
Chronic pain after inguinal hernia repair can be fundamentally divided into 
neuropathic pain and non-neuropathic pain (nociceptive pain) [Kehlet et al., 
2006; Massaron et al., 2007].  
To understand the etiology of nerve injury and to prevent nerve entrapment 
in inguinal hernia repair, a complete knowledge of the nerves located in the 
inguinal region is necessary. When the inguinal region is explored through the 
anterior approach, the ilioinguinal nerve, the genital branch of the genitofemoral 
nerve and the iliohypogastric nerve are at a risk of damage [Ferzli et al., 2007]. 
With open surgery the ilioinguinal nerve can be identified lateral to the internal 
ring, and between the ring and the anterior superior iliac spine. The iliohypo-
gastric nerve is identified within the anatomic cleavage between the external 
and internal oblique aponeurosis. The inguinal segment of the genital branch of 
the genitofemoral nerve can be identified between the cord and the inguinal 
ligament and traced laterally to the internal ring [Bjurstrom et al., 2014]. The 
ilioinguinal nerve, the genital branch of the genitofemoral nerve and the 
iliohypogastric nerve are present at a mean of 96, 90 and 94 %, respectively 
[Alfieri et al., 2011]. Although there exist great variations in the nerves [Amid, 
2004b], in 70–90 % of cases it is possible to identify all three inguinal nerves as 
three separate nerves [Alfieri et al., 2011].  
According to the IASP, neuropathic pain is initiated or caused by primary 
lesion or dysfunction of the nervous system [Merskey and Bogduk, 1994]. The 
causes of neuropathic pain are nerve entrapment by mesh or sutures and 
neuroma formation associated with partial or complete transection of the 
involved nerve [Amid, 2004b; Ferzli et al., 2007].  
Neuropathic pain can occur immediately after operation but not infrequently 
it can also occur after months or years. The pain is burning and radiates to the 
area supplied by the sensory nerve [Merskey and Bogduk, 1994].  
For the iliohypogastric nerve, the pain radiates to the midline above the 
pubis and laterally to the hip region. For the ilioinguinal and the genitofemoral 
nerves, the pain radiates from the groin into the scrotum and penis or into the 
anterior part of the labia major and on the inside or the anterior surface of the 
thigh. Usually the pain is continuously present, but it is activity induced and 
therefore can be intensified by stretching of the hip joint, coughing, sneezing, 
sexual intercourse and general tension in the abdominal muscles, which results 
in nerve traction or compression [Loos et al., 2007; Merskey and Bogduk, 
1994].  
The diagnostic criteria for neuralgia in the inguinal region are burning pain 
with superimposed paroxysms in the distribution of the involved nerve, in-
creased sensation of light touch or pinprick sensation, reproduction of paro-
xysmal pain by tapping neuromata at the site of nerve injury and transient pain 
relief from proximal local anaesthetic block [Merskey and Bogduk, 1994].  
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Nociceptive pain results from activation of high threshold peripheral sensory 
(nociceptor) neurons from local activation of inflammatory mediators [Kehlet et 
al., 2006] due to continuous inflammatory reaction around the mesh [Aasvang 
et al., 2008; Alfieri et al., 2011]. According to Amid, nociceptive pain is caused 
by the mechanical pressure of mesh on the adjacent tissue including vas defe-
rens and nerves [Amid, 2004b]. Nociceptive pain is described as aching, 
stabbing, throbbing, sharp or gnawing [Massaron et al., 2007] and it is  constant 
pain aggravated by strenuous exercise [Vuilleumier et al., 2009].  
 
 
2.9.2. Risk factors for development of chronic pain 
The risk factors for development of chronic pain are younger age, preoperative 
pain, severe early postoperative pain and female sex [Simons et al., 2009]. 
According to Reddi et al., mild preoperative pain is not a risk factor for 
development of chronic pain; postoperatively also acute moderate pain, not only 
acute severe pain, is a predictive factor for development of chronic pain [Reddi 
and Curran, 2014].  
Poobalan et al. found that patients who were aged under 40 years had an 
increased risk for development of chronic pain [Poobalan et al., 2001]. Also in a 
systematic review of Nienhuijs et al. and in a study of Bay-Nielsen et al. 
chronic pain was associated with lower mean age [Bay-Nielsen et al., 2001b; 
Nienhuijs et al., 2007]. This can be explained by the fact that younger people 
are usually more active [Kalliomaki et al., 2008]. 
In a study of Poobalan et al. patients who reported pain preoperatively had 
an increased risk for development of chronic pain [Poobalan et al., 2001]. In 
another study preoperative pain had a predictive value for development of  
chronic pain [Wright et al., 2002].  
In a study of Callesen et al. the rate of chronic pain at 1-year follow-up was 
higher in patients who had a high pain score 1 week after operation [Callesen et 
al., 1999].  
In a review of Aasvang et al. it was found that females are at a higher risk of 
developing chronic pain than males [Aasvang and Kehlet, 2005].  
 
 
2.9.3. Assessment of chronic pain 
Pain is a highly subjective experience and is therefore difficult to objectify. Se-
veral different scales (visual analogue scale (VAS), numeric rating scale, 
McGill pain questionnaire, Short form McGill pain questionnaire, chronic pain 
grade scale, Short form 36 bodily pain scale) have been developed to quantify 
pain.  
The VAS is a continuous scale comprising a horizontal or vertical line, 
usually 100 mm in length. For pain intensity, the scale is most commonly 
anchored by „no pain“ (score of 0) or „worst imaginable pain“ (score of 100) 
(Figure 6). To avoid clustering of scores around a preferred numeric value, 
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numbers or vertical descriptors at intermediate points are not recommended 
[Hawker et al., 2011; van Hanswijck de Jonge et al., 2008]. Patients are asked to 
mark a point on the line where they think their pain is [van Hanswijck de Jonge 
et al., 2008].  
 
 
No pain                                                                                                  Worst 
imaginable pain 
 
Figure 6 Visual analogue pain scale 
 
 
2.9.4. Impact of different mesh parameters 
 on chronic pain 
Usage of foreign material in hernia surgery can induce stronger inflammatory 
reaction [Klinge et al., 1999], which can result in chronic pain. The pain may be 
caused by damage to the inguinal nerves, but there is also association between 
the rate of chronic postoperative pain and the type of foreign material used for 
alloplasty. 
Different mesh characteristics have been studied, among them weight of 
mesh has probably gained the most attention. The rate of chronic pain varies 
significantly in different studies. In a study of O’Dwyer et al. 39.5 % of patients 
in the LW (lightweight) group and 51.6 % in the HW (heavyweight) group 
reported pain of any severity at the site of hernia repair 12 months after 
operation (P=0.033), among them 3 % of the patients in the LW group and 4 % 
of the patients in the HW group experienced severe or very severe pain 
[O'Dwyer et al., 2005]. Also Post et al. reported that usage of lightweight mesh 
in a subgroup analysis of 70 physically active patients was associated with 
significantly less pain on exercise at 6-month follow-up, whereas no patient 
reported severe pain but, unfortunately, the exact rates of chronic pain were not 
presented [Post et al., 2004]. In a study by Bringman et al. groin pain was 
experienced by 10.3 % in the LW group and 12.2 % in the HW group at 1-year 
follow-up (P=0.49) [Bringman et al., 2005]. At 3-year follow-up less patients in 
the LW group reported pain during different activities (at rest, on coughing, 
when rising from lying to sitting and during physical activity), but it reached 
statistical significance only during rising from lying to sitting [Bringman et al., 
2006]. According to Smietanski et al., there was no statistically significant 
difference in terms of pain between the LW and HW groups at 6- and 12-month 
follow-up. Of the patients 10.7 % in the LW group and 9.9 % in the HW group 
suffered from pain 6 months after operation. The rates of chronic pain at 12-
month follow-up were 3.8 % and 6.2 %, respectively [Smietanski, 2008] and at 
3-year follow-up 2.6 % and 2.5 %, respectively [Bury and Smietanski, 2012]. In 
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the most recent study comparing lightweight and heavyweight mesh, the rate of 
chronic pain in the LW group was 16.7 % and in the HW group 21.8 % at 6-
month follow-up, but it did not reach statistical significance. Although the 
difference between the two study groups was insignificant also at 1-year follow-
up, the rates of chronic pain decreased to 7.4 % in the LW group and to 5.5 % in 
the HW group [Yazdankhah Kenary et al., 2013]. 
Also several systematic reviews and meta-analyses comparing lightweight 
and heavyweight meshes have revealed reduced rates of chronic pain in the LW 
group [Li et al., 2012; Sajid et al., 2012; Smietanski et al., 2012; Zhong et al., 
2013; Uzzaman et al., 2012]. Li et al. included open and laparoscopic repairs in 
their study [Li et al., 2012], which in the opinion of Memon et al. is  like 
comparison of apples and oranges [Memon et al., 2012]. Smietanski et al. 
evaluated also severe chronic pain but found no significant difference between 
the two mesh types concerning severe pain [Smietanski et al., 2012]. 
When reduction in weight has resulted in lower chronic pain rates in many 
studies, self-gripping meshes have not yielded promising results. In a pro-
spective study the usage of self-gripping mesh resulted in a 2.8 % rate of chro-
nic pain at 6-month follow-up [Garcia Urena et al., 2011] and 4 % at a median 
follow-up of 17 months [Pedano et al., 2012]. In a randomised study of 
Jorgensen et al., comparing self-gripping and sutured mesh for the open 
inguinal hernia repair, the rate of pain at 1-year follow-up was 9.9 % in the self-
gripping group and 7.7 % in the sutured mesh group (P=0.561) [Jorgensen et 
al., 2013]. A study of Pierides et al. found no difference between the self-
gripping and the sutured mesh group in terms of chronic pain one year after 
hernia repair, either [Pierides et al., 2012]. Although in a study of Kingsnorth et 
al. there were significant differences in the change of VAS scores at discharge 
and at one week follow-up, compared with baseline, there were no differences 
in VAS scores or in the rate of chronic pain at 3-month follow-up [Kingsnorth 
et al., 2012]. Chatzimavroudis et al. reported higher rates of chronic pain in the 
self-gripping mesh group at 1- and 2-year follow-up (16 % versus 12 % and 8 % 
versus 4 %, respectively), but the differences were statistically insignificant 
[Chatzimavroudis et al., 2014]. 
There are also several systematic reviews and meta-analyses comparing self-
gripping mesh and sutured mesh, where self-gripping mesh has failed to 
demonstrate reduced rates of chronic pain after open inguinal hernia repair 
[Fang et al., 2014; Li et al., 2014; Pandanaboyana et al., 2014; Sajid et al., 2014; 
Zhang et al., 2013]. 
Like the usage of self-gripping mesh, also the usage of absorbable sutures 
has not resulted in lower rates of chronic pain after inguinal hernia repair. In a 
study of Paajanen 26 % of the patients in the study group where absorbable 
sutures were used and 24 % of the patients in the group where non-absorbable 
sutures were used reported pain at 2-year follow-up [Paajanen, 2002]. 
Several studies compared meshes with different pore sizes, however, the 
investigated meshes differed not only in pore size but also in weight [Bringman 
et al., 2006; Bury and Smietanski, 2012; O'Dwyer et al., 2005]. 
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2.9.5. Surgical treatment of chronic pain  
The choice of adequate therapy for chronic groin pain after inguinal hernia re-
pair is controversial [Campanelli et al., 2013]. The EHS recommends to con-
sider a multidisciplinary approach at a pain clinic for treatment of chronic post-
operative pain [Simons et al., 2009]. It should be recognized that chronic post 
hernioplasty pain may be multifactorial and it is possible that specific etiology 
is not identifiable [Ferzli et al., 2008]. 
Although surgical treatment of chronic post hernioplasty pain is restricted 
because of the lack of scientific data, resection of entrapped nerves, mesh 
removal in mesh-related pain or removal of fixating sutures can be considered 
[Simons et al., 2009]. According to the international guidelines for prevention 
and management of chronic posthernioplasty pain the reasonable time point for 
surgical treatment is 1 year postoperatively, when the inflammatory response 
has decreased. Surgical treatment should be considered only when pain curtails 
activities [Alfieri et al., 2011] and conventional non-invasive treatment has 
failed [Alfieri et al., 2011; Palumbo et al., 2007]. Although there is no good 
evidence of the efficacy of local anaesthetic blocks in chronic posthernioplasty 
pain, the potential for local anaesthetic blocks should be considered in 
predicting surgical outcome: if a diagnostic nerve block is ineffective, patients 
will most likely not benefit from surgical treatment [Werner, 2014]. 
It is difficult or even impossible to pinpoint the involved nerve because of 
common peripheral communication between the three nerves [Amid, 2004b; 
Hakeem and Shanmugam, 2011]; the innervation field of the three nerves over-
laps and frequently more than one nerve can cause postoperative neuropathic 
pain [Amid, 2004b]. Therefore, when surgical treatment is indicated, triple 
neurectomy, including the intramuscular segment of the iliohypogastric nerve, 
should be performed [Alfieri et al., 2011]. However, search for the nerves 
involved in the scar tissue can be extremely difficult [Palumbo et al., 2007]. 
Neurectomy does not address the nociceptive component caused by meshoma 
or neuropathic testicular pain [Bjurstrom et al., 2014]. 
Earlier, a two-stage operation, including ilioinguinal and iliohypogastric 
neurectomies through an inguinal approach and genitofemoral neurectomy 
through a posterior flank approach, has been advised [Starling and Harms, 
1989].  
According to Amid, surgical treatment of chronic posthernioplasty pain 
consists of one-stage resection of the entire length of the nerves as far  proximal 
and distal as possible in order to include the involved segment. The transected 
nerve ends should be ligated in order to prevent neuroma formation. The ligated 
ends of the ilioinguinal and iliohypogastric nerves should be implanted within 
the internal oblique muscle, which prevents adherence of the cut ends to the 
inguinal ligament and external oblique aponeurosis, in order to prevent 
recurrence of pain. In the case of the genital branch of the genitofemoral nerve, 
the proximal cut end of the nerve is ligated with the nerve under tension in order 
to allow retraction of the nerve into the internal ring. As reported by Amid, 80 
% of the patients recovered completely after one-stage triple neurectomy 
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[Amid, 2004b]. The advantages of the open approach are the possibility to 
perform a single stage operation for triple neurectomy, as well as to remove 
meshoma when necessary. The disadvantage of the approach is its technical 
difficulty when operating within the scarred field, placing the spermatic cord 
and vascular structures at a higher risk of compromise [Bjurstrom et al., 2014].  
In a study of Campanelli et al. a simultaneous double approach (ilioinguinal 
and iliohypogastric nerves by the anterior approach, genitofemoral trunk by 
posterior pre-peritoneal approach from the same skin incision) triple neurecto-
my (in 44/46 cases) was used, resulting in resolution of pain  in 87 % of cases 
[Campanelli et al., 2013].  
Endoscopic retroperintoneal neurectomy for chronic pain after inguinal 
hernia repair has also been described [Giger et al., 2009; Muto et al., 2005]. Ac-
cording to Giger et al., the severity of chronic pain decreased significantly after 
endoscopic neurectomy in 37 of the 39 patients compared to preoperative values 
[Giger et al., 2009].  
However, the unreasonable failure to treat pain is an abrogation of funda-
mental human rights [Brennan et al., 2007] and therefore surgical treatment of 
chronic posthernioplasty pain should definitely be considered for patients in 
whom conservative pain management treatment has failed.  
 
 
2.10. Foreign body feeling 
Many patients report a feeling of a foreign body after implantation of mesh in 
the groin [Post et al., 2004], which is probably the result of foreign body 
reaction. Therefore, it is speculated that meshes whose usage causes less foreign 
body reaction cause also less chronic symptoms, including foreign body feeling, 
which results in subjective improvement [Post et al., 2004]. According to 
Bringman et al., a successful procedure is one in which a patient has no 
sensation of foreign body and can return quickly to normal activities [Bringman 
et al., 2010]. However, according to Smietanski et al., the clinical relevance of 
foreign body feeling is unknown and although it is reported by patients, it is not 
likely to influence daily activities and quality of life [Smietanski et al., 2012].  
Foreign body feeling is usually assessed as a yes-or-no question [Bringman 
et al., 2006; Post et al., 2004].  
In a study of Post et al. significantly less patients reported foreign body 
feeling in the LW group compared with the HW group after the Lichtenstein 
repair (17.2 versus 43.8 %) at 6-month follow-up [Post et al., 2004]. Also 
Bringman et al. reported less foreign body feeling in the LW group compared 
with the HW group (14.7 versus 22.6 %) at 3-year follow-up [Bringman et al., 
2006]. In meta-analyses comparing lightweight and heavyweight meshes the 
presence of foreign body feeling was dominating in the LW group [Smietanski 
et al., 2012; Uzzaman et al., 2012]. However, in a study comparing self-
gripping mesh and sutured mesh, there was no difference in foreign body 
feeling between the study groups at 1-year follow-up [Pierides et al., 2012]. In a 
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prospective study self-gripping mesh resulted in a 8.9 %  rate of foreign body 
feeling at 6-month follow-up [Garcia Urena et al., 2011]. Also in a prospective 
study of self-gripping mesh the rate of foreign body feeling at a median follow-
up of 17 months was 2 % [Pedano et al., 2012].  
 
 
2.11. Quality of life 
Quality of life is a measure increasingly used to evaluate the success of treat-
ment [Pierides et al., 2013]. Different questionnaires have been developed and 
used to assess quality of life and its changes after treatment, including inguinal 
hernia repair (RAND SF 36; Short Form 36, SF36; Core Outcome Measures 
Index, COMI; EuroQol; EQ-5D) [Palmqvist et al., 2013; Staerkle and Villiger, 
2011].  
The RAND SF36 1.0 questionnaire is a generic quality of life questionnaire. 
It is the same as the Short Form Health Survey, except for the scoring algorithm 
of two domains. The RAND SF36 measures 8 domains of health: general 
health, vitality, bodily pain, mental health, social functioning, physical functio-
ning, emotional role (limitations caused by emotional problems) and physical 
role (limitations caused by physical health). The RAND SF36 questionnaire’s 
score 100 represents the best possible health [Hays et al., 1993]. The RAND 
SF36 has been validated for the Estonian population [Lai, 2012].  
According to Post et al., there was no difference in the quality of life scores 
between the LW and HW groups, but regardless of the type of mesh implanted, 
the quality of life scores improved significantly in most domains after surgery at 
6-month follow-up, compared with the preoperative scores [Post et al., 2004]. 
Also in a study of Bringman et al. there were no differences in the quality of life 
scores between the LW and the HW groups at 1-year follow-up [Bringman et 
al., 2005]. 
Although quality of life assessment is frequently used to evaluate the effects 
of treatment, Mathur et al. have measured quality of life in patients with 
inguinal hernia on the elective waiting list for repair. According to their study, 
patients with inguinal hernia have significantly impaired quality of life com-
pared with age-, sex- and comorbidity-matched controls [Mathur et al., 2006]. 
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3. AIMS OF THE STUDY 
1. To evaluate the rate of chronic pain after open inguinal hernia repair in the 
case of using different meshes and to clarify which mesh parameters have a 
significant influence on the development of chronic pain. 
2. To evaluate the rate of foreign body feeling after open inguinal hernia repair 
in the case of using different meshes and to clarify which mesh parameters 
have a significant influence on the development of foreign body feeling. 
3. To evaluate patients’ quality of life after inguinal hernia repair.  
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4. MATERIAL AND METHODS 
4.1. Inclusion and exclusion criteria 
All patients scheduled for inguinal hernia repair at the Surgery Clinic of Tartu 
University Hospital, Department of General Surgery, in the following time pe-
riods, who met the inclusion criteria, were eligible to participate in the studies: 
from 1/2007 to 7/2008 (I, II) 
from 1/2011 to 4/2012 (III) 
from 1/2012 to 6/2013 (IV) 
The eligible patients were adults aged 18 years or older with unilateral primary 
reducible inguinal hernia, providing consent for participation in the study. 
Patients younger than 18 years and patients with irreducible, strangulated or 
recurrent hernia were excluded. Also patients who were unable to understand 




The patients were randomised to 1 of 2 parallel study groups. Randomisation 
was done using a set of sealed opaque envelopes, which were all prepared by 
one investigator (CN) prior to commencement of the study. The envelopes were 
kept in an arranged location in the operating room. Before operation, the 
surgeon took randomly a sealed envelope that contained a label of mesh. The 
patients were blinded to which mesh they received. 
 
 
4.3. Meshes and operation technique 
4.3.1. Lightweight versus heavyweight mesh (I, II) 
In the HW group the patients received Premilene® Mesh (B. Braun Melsungen 
AG, Melsungen, Germany); in the LW group the patients received Optilene® 
Mesh LP (B. Braun).  
Premilene® Mesh is a monofilament polypropylene mesh with a pore size of 
0.8 mm and a weight of 82 g/m². Optilene® Mesh LP is monofilament poly-
propylene mesh with a pore size of 1.0 mm and a weight of 36 g/m².  
A tension-free hernioplasty, using the modified Lichtenstein technique, was 
performed in both study groups. The operative technique was based on the 
description of Amid [Amid, 2004a], except that indirect hernia sacs were freed 
from the cord, ligated and resected and the upper edge of the mesh was sutured 
in place with more than two interrupted sutures. In both groups a mesh of 4.5 x 
10 cm was applied and polypropylene 2/0 suture material was used for mesh 
implantation. All nerves in the inguinal canal were identified and preserved 
when possible. 
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4.3.2. Pore size study (III) 
In the UM group the patients received Ultrapro® mesh (Ethicon, Hamburg, Ger-
many);  in the OM group the patients received Optilene® LP mesh (B. Braun).  
Ultrapro® is a lightweight partially absorbable mesh consisting of polypro-
pylene and polyglecaprone with a weight of 28 g/m² and a pore size of 3–4 mm. 
The resorption time of polyglecaprone is 84–140 days [Klosterhalfen et al., 
2005]. Optilene® LP mesh is a monofilament polypropylene lightweight mesh 
with a weight of 36 g/m² and a pore size of 1 mm.  
A tension-free repair using the modified Lichtenstein technique was per-
formed in both study groups. The operative technique was based on the 
description of Amid [Amid, 2004a], except that indirect hernia sacs were freed 
from the cord, ligated and resected and the upper edge of a mesh was sutured in 
place with more than two interrupted sutures. A mesh with measurements 4.5 x 
10 cm was applied, while Optilene® LP mesh was commercially preshaped and 
Ultrapro® mesh was shaped by the surgeon during the operation, by using a 
stencil. Polyprolylene 2/0 suture material was used for mesh implantation. All 
nerves in the inguinal canal were identified and preserved when possible. 
 
 
4.3.3. Self-gripping versus sutured mesh (IV) 
In the OLP group the patients received Optilene® LP mesh (B. Braun); in the 
PPG group the patients received Parietex ProGrip mesh (Covidien, Trevoux, 
France).  
Optilene® LP mesh is a monofilament polypropylene lightweight mesh with 
a weight of 36 g/m² and a pore size of 1 mm. Parietex ProGrip™ mesh is a 
partially absorbable monofilament mesh consisting of polyester and polylactic 
acid with a weight of 74 g/m² before resorption and 38 g/m² after resorption and 
a pore size of 1.1 x 1.7 mm. Parietex ProGrip™ mesh has microgrips across its 
surface area, which ensure gripping between muscle fibres and the connective 
tissue. The resorption time of polylactic acid is 12 months [Chastan, 2009]. 
Both meshes are commercially preshaped. Optilene® LP mesh with measure-
ments 6 x 14 cm and Parietex ProGrip™ mesh with measurements 8 x 12 cm 
were used.  
A tension-free hernioplasty, using the modified Lichtenstein technique, was 
performed in the OLP group. The operative technique was based on the 
description of Amid [Amid, 2004a], except that indirect hernia sacs were freed 
from the cord, ligated and resected and the upper edge of the mesh was sutured 
in place with more than two interrupted sutures. Polyprolylene 2/0 suture 
material was used for mesh implantation. In the PPG group the inguinal canal 
was prepared and the wound was later closed as in the standard Lichtenstein 
operation. The mesh was placed in position in the inguinal canal, the flaps were 
closed around the cord and pressure was applied to the mesh for fixing it. All 
nerves in the inguinal canal were identified and preserved when possible in both 
study groups. 
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4.4. Preoperative data and follow-up visits 
The patients were examined after 7 days, 1 month, and 6 months. In the study 
comparing the weight of the meshes, follow-up examination was performed also 
3 years after the operation. 
The preoperative and postoperative data were documented using stan-
dardised forms. The data included demographic data, body mass index, duration 
of the disease, method of anaesthesia, type of hernia (direct or indirect), size of 
hernia, hernial sac handling, mesh used, duration of operation, length of hospital 
stay and experience of the surgeon (trainee or staff surgeon). 
The patients were examined for any evidence of wound infections, haema-
tomas, seromas and recurrent hernia at every postoperative follow-up visit. The 
patients were inquired about postoperative analgesic consumption. 
 
 
4.5. Chronic pain 
The primary endpoint of three randomised studies was the rate of chronic groin 
pain at 6-month follow-up, taking into account all patients who reported pain 
during different activities (yes-or-no questions).  
The pain questionnaire was completed before the  operation and during 
follow-up visits at week 1, month 1 and month 6 and, in the case of the study 
comparing the weight of the meshes, also at year 3.  
The pain questionnaire included questions about pain at rest, on coughing, 
when rising from lying to sitting and during physical effort and exercise (all 
yes-or-no questions). When patients’ response to the questionnaire was positive, 
the pain scores were measured on a visual analogue scale (VAS) ranging from 0 
mm (no pain) to 100 mm (worst imaginable pain). A score less than  10 was 
graded as mild pain, a score 10–50, as moderate pain, and a score more than 50, 
as severe pain. Such gradation has been used in similar studies [Page et al., 
2002]. The analysis of the distribution of pain severity was based on the highest 
score on the visual analogue scale during different activities (at rest, on 
coughing, when rising from lying to sitting, and during physical effort and 
exercise). Data about whether pain influenced the patients’ everyday activities 
were recorded as well. 
 
 
4.6. Foreign body feeling 
Foreign body feeling was a secondary outcome measure.  
Foreign body feeling was registered as a yes-or-no question and the data 
were collected at follow-up visits at week 1, month 1 and month 6 and, in the 
case of the study comparing weight of meshes, also at year 3.  
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4.7. Quality of life 
Quality of life was a secondary outcome measure.  
Quality of life was evaluated using the RAND SF36 questionnaire, which 
was completed before the operation and 6 months after the operation. The SF36 
questionnaire is a generic quality of life questionnaire, which measures 8 
domains of health: general health, vitality, bodily pain, mental health, social 
functioning, physical functioning, emotional role and physical role. The SF36 
questionnaire’s score 100 represents the best possible health [Hays et al., 1993]. 
 
 
4.8. Statistical analysis 
4.8.1. Lightweight versus heavyweight mesh (I, II) 
A sample size of 114 eligible patients (57 in each group) was necessary to en-
sure the 80% power to detect a benefit of 25% for lightweight mesh for primary 
efficacy (rate of chronic pain at 6 months: HW mesh, 40%; LW mesh, 15 %). 
The study groups were analysed per protocol principle. Patients who were 
lost during follow-up were excluded from the analysis; only the patients who 
completed the questionnaire were included. 
The data of 1-week, 1-month and 6-month follow-up visits were analysed 
using the Statistica® version 8.0 software package (StatSoft, Tulsa, USA) for 
Windows XP Professional (Microsoft Inc., USA), the data of 3-year follow-up 
were analysed using the Statistica® version 10.0 software package for Windows 
XP Professional. The χ² and Fisher’s exact tests were used to assess differences 
between categorical data. Scores on the VAS were compared by the Mann-
Whitney U test. To analyse quality of life scores, the t-test was used. All 
statistical tests were two-sided and p≤0.05 was considered significant.  
 
 
4.8.2. Pore size study (III) 
In the study comparing the weight of the meshes the rate of chronic pain in the 
group, where also Optilene® LP mesh was used was 47.8 % [Nikkolo et al., 
2010]. In a study of Smietanski et al. the rate of pain (VAS>0) after inguinal 
hernia repair with Ultrapro mesh was 21.2 % [Śmietański et al., 2009]. Based 
on previous research, to show that the difference in the rate of chronic pain for 
OM 48 % vs UM 21 % would be about 27 % according to Fisher’s exact test at 
the 5 % significance level (power 80%), a sample size of 56 patients was 
necessary. Considering the drop-out rate to be 5 %, a minimum of 118 parti-
cipants were needed for the study. 
The study groups were analysed per protocol principle. The patients who 
were lost during follow-up were excluded from the analysis; only the patients 
who completed the questionnaire were included.  
The data were analysed using the Statistica® version 10.0 software package 
for Windows XP Professional. To test the primary hypothesis (rate of chronic 
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pain in the two study groups at 6-month follow-up), Fisher's exact test was used. 
To describe associations for the binary outcome variables, risk ratios with 95% 
confidence intervals were reported. A logistic regression model was used to 
control for confounding variables (adjusting for sex, age groups (age <65 vs. 
≥65 years) and severe preoperative pain). VAS scores were analysed by fitting a 
linear mixed model with the explanatory between-group variable (mesh usage) 
and the within-group variable (time) to the data. Analysis of covariance was 
used to evaluate association between quality of life scores at 6-month follow-up 
and type of mesh, while adjusting for the effect of the preoperative quality of 
life scores. All statistical tests were two-sided and P≤0.05 was considered 
significant. 
 
4.8.3. Self-gripping versus sutured mesh (IV) 
To demonstrate that the rate of chronic pain between the study groups would 
decrease by 25 % according to Fisher’s exact test at the 5 % significance level 
(power 80%), a sample size of 65 patients was calculated (the rate of chronic 
pain in the OLP group 48 % and in the PPG group 23 %). The rate of chronic 
pain in the OLP group was based on the results of our previous study [Nikkolo 
et al., 2010]. 
The study groups were analysed per intention-to-treat principle. The 
patients’ data which were lost because of drop-out were replaced with data from 
the last completed follow-up, except for the quality of life scores where the 
median scores for the study group were used.  
The data were analysed using the Statistica® version 12.0 software package 
for Windows XP Professional. Fisher's exact test was used to test the primary 
hypothesis. To describe associations for binary outcome variables, risk ratios 
with 95% confidence intervals were reported. A logistic regression model was 
used to control presence of pain at 6 months for confounding variables 
(adjusting for age groups (age <65 vs. ≥65 years), severe preoperative pain 
(VAS≤50 vs. VAS>50), severe early postoperative pain (VAS≤50 vs. VAS>50 
at 1-week follow-up)). VAS scores were analysed by fitting a linear mixed 
model with the explanatory between-group variable (mesh usage) and the 
within-group variable (time) to the data. Analysis of covariance was used to 
evaluate association between quality of life scores at 6-month follow-up and 
type of mesh while adjusting for the effect of the preoperative quality of life 





5.1. Lightweight versus heavyweight mesh (I, II) 
The study flow chart is presented in Figure 7.  
The patient and operative data are presented in Table 2.  
According to the primary endpoint, 59.4 % of the patients in the HW group 
and 47.8 % of the patients in the LW group experienced pain of any severity 
(VAS score ≥1) during any physical activity at 6-month follow-up (P=0.221). 
The respective results at 3-year follow-up were 17.2 % and 29.3 % (P=0.132). 
Comparison of the results of 6-month follow-up and 3-year follow-up revealed 
that the rate of chronic pain had decreased significantly in the HW group 
(P<0.001) and as well as in the LW group (P=0.03).  
Positive responses to the pain questionnaire at 6-month follow-up are 
presented in Table 3 and at 3-year follow-up in Table 4. Differences in the 
median VAS scores for the study groups were statistically insignificant. Mean 
VAS scores and 95 % confidence intervals based on the highest VAS score for 
different activities before operation, and at 1-week, 1-month and 6-month 
follow-up, are presented in Figure 8. At 3-year follow-up the mean VAS scores 
were 34.3 in the HW group and 32.5 in the LW group. There was no significant 
difference in the distribution of pain severity between the HW group and the 
LW group at 6-month follow-up (Table 5). As only a few patients reported pain 
during different activities (at rest, on coughing, when rising from lying to sitting 
and during physical activity) at 3-year follow-up, the distribution of pain 
severity is not informative and will not be presented. Comparison of the 6-
month follow-up VAS scores and the three-year follow-up VAS scores for the 
most painful activity showed that there were 6 patients in the HW group and 12 
patients in the LW group who had reported stronger pain at three-year follow-
up (P=0.135).  
Of all studied patients under the age of sixty-five, 25.7 % reported chronic 
pain at three-year follow-up. The corresponding result for patients over the age 
of sixty-five at 3-year follow-up was 16.7 % (P=0.26).  
At three-year follow-up 42.9 % of the patients who had had severe pain 
(VAS score >50) preoperatively also reported pain during different activities 
and 19.6 % of the patients who had not had severe pain preoperatively (VAS 
score <50) reported pain during different activities (P=0.048).  
Of the patients 41.7 % who had severe pain on the 7th postoperative day had 
also pain at three-year follow-up. However, 20.2 % of the patients who did not 
report severe pain on the 7th postoperative day had pain during different 
activities at three-year follow-up (P=0.081) 
Only 9.4% of patients in the HW group and 6% of the patients in the LW 
group had pain at the operation site after 6 months, which influenced their daily 
activities (p=0.463). At three-year follow-up 5.2 % of the patients in the HW 
group and 6.9 % of the patients in the LW group had pain at the operation site, 
which influenced their daily activities (P=0.999). 
35 
There was no difference in analgesic consumption between the study groups. 
The analgesics used against pain were non-steroidal anti-inflammatory drugs 
(NSAID); no combination of a NSAID and an opioid was used in this study. 
Altogether 93.8% of the patients in the HW group and 98.5% of the patients in 
the LW group did not use any analgesics after 6 months. Only one patient in the 
HW group used analgesics for groin pain at 3-year follow-up.  
Foreign body feeling at the operation site was experienced by 32.8% of the 
patients in the HW group and by 20.9% of the patients in the LW group after 6 
postoperative months (p=0.123). At 3-year follow-up, there were also more 
patients in the HW group than in the LW group who stated that they could feel 
the mesh in the groin (27.6 vs. 20.7 %, P=0.397). Among them 11 patients in 
the HW group and 8 patients in the LW group reported foreign body feeling at 
6-month follow-up but no foreign body feeling at three-year follow-up. Eight 
patients in the HW group and 9 patients in the LW group had no foreign body 
feeling at 6-month follow-up but had developed it by three-year follow-up. Of 
the patients 37.5 % in the HW group who reported foreign body feeling had also 
pain during different activities at 3-year follow-up. At the same time, 9.5 % of 
the patients in the HW group who had no foreign body feeling at three-year 
follow-up reported pain during different activities (P=0.011). In the LW group 
the respective results at 3-year follow-up were 58.3 % and 21.7 % (P=0.016). 
Comparison of the relevant data for the two study groups revealed no signi-
ficant difference. 
There were no significant differences in any dimension of quality of life on 
the SF36 questionnaire between the two study groups 6 months after surgery. 
However, both study groups showed a significant improvement in the post-
operative scores, in comparison with the preoperative scores, in all dimensions 
except for general health (Table 6). 
At three-year follow-up there was 1 hernia recurrence in the HW group and 
1 hernia recurrence in the LW group. The overall recurrence rate, expressed 
with respect to the number of patients who completed postoperative follow-up, 






















































































































Mean age (years) 57.2 59.2 
Sex ratio M:F 60:4 (93.8:6.3 %) 61:6 (91:9 %) 
BMI (kg/m²) 25.5 (17.7–33.6)ª 25 (17.5–32.9)ª 
Mean time from hernia 
occurrence to operation 
(months) 






23 (35.9 %) 
38 (59.4 %) 
3 (4.7 %) 
 
34 (50.8 %) 
31 (46.3 %) 
2 (3 %) 





13 (20.3 %) 
43 (67.2 %) 
8 (12.5 %) 
 
11 (16.4 %) 
49 (73.1 %) 








20 (31.3 %) 
4 (6.3 %) 
33 (51.6 %) 
5 (7.8 %) 
2 (3.1 %) 
 
28 (41.8 %) 
1 (1.5 %) 
35 (52.2 %) 
2 (3 %) 
1 (1.5 %) 
Mean operating time 
(min) 





40 (62.5 %) 
24 (37.5 %) 
 
31 (46.3 %) 
36 (53.7 %) 
 
ª Minimal and maximal values are shown in the parentheses 














Table 3. Positive answers to the pain questionnaire at 6-month follow-up after inguinal 










38 (59.4 %) 32 (47.8 %) 0.221 
Pain in the groin 
at rest 
4 (6.3 %) 0 0.054 
Pain in the groin 
on coughing 
2 (3.1 %) 3 (4.5 %) 0.999 
Pain in the groin 
when rising from 
lying to sitting 
5 (7.8 %) 3 (4.5 %) 0.486 
Pain in the groin 
during physical 
activity 
15 (23.4 %) 13 (19.4 %) 0.671 
*Fisher’s exact test 
**The rate of chronic groin pain at 6-month follow-up, taking into account all patients 
who reported pain during different activities 
HW heavyweight mesh, LW lightweight mesh 
 
 
Table 4. Positive answers to the pain questionnaire at 3-year follow-up after inguinal 










10 (17.2 %) 17 (29.3 %) 0.132 
Pain in the groin 
at rest 
2 (3.5 %) 2 (3.5 %) 0.999 
Pain in the groin 
on coughing 
0 3 (5.2 %) 0.999 
Pain in the groin 
when rising from 
lying to sitting 
5 (8.6 %) 0 0.999 
Pain in the groin 
during physical 
activity 
7 (12.1 %) 14 (24 %) 0.999 
 
*Fisher’s exact test 
**The rate of chronic groin pain at 3-year follow-up, taking into account all patients 
who reported pain during different activities 










Figure 8. Mean visual analogue scale scores and 95 % CI based on the highest score for 
different activities before and after operation (lightweight versus heavyweight mesh I) 


















Table 5. Distribution of pain severity based on the highest pain score on the visual 














5 (7.8 %) 
13 (20.3 %) 
40 (62.5 %) 
6 (9.4 %) 
 
10 (14.9 %) 
17 (25.4 %) 
32 (47.5 %) 










5 (7.8 %) 
14 (21.9 %) 
36 (56.3 %) 
9 (14.1 %) 
 
 
3 (4.5 %) 
23 (34.3 %) 
38 (56.7 %) 











14 (21.9 %) 
31 (48.4 %) 
18 (28.1 %) 
1 (1.6 %) 
 
 
22 (32.8 %) 
30 (44.8 %) 
14 (20.9 %) 











26 (40.6 %) 
23 (35.9 %) 




35 (52.2 %) 
23 (34.3 %) 




































































































































































































































































































































































































































































































































5.2. Pore size study (III) 
The study flow chart is presented in Figure 9.  
The patient and operative data are presented in Table 7.  
According to the primary endpoint, 46.3 % of the patients in the UM group 
and 34.3 % of the patients in the OM group reported having experienced pain 
during different activities at 6-month follow-up (P=0.165). This suggests that 
chronic pain was about 1.35 (95 % CI 0.89, 2.06) times more likely to occur in 
the UM group but not at a statistically significant level. 
There were no significant differences in the results of the pain questionnaire 
for different activities between the study groups at follow-up visits. Positive 
answers to the pain questionnaire at 6-month follow-up are presented in Table 
8. Differences in the VAS scores for the two treatment groups were statistically 
insignificant (P=0.699). Mean VAS scores and 95 % confidence intervals based 
on the highest VAS score for different activities before operation and after 
operation are presented in Figure 10. There was no significant difference in the 
distribution of pain severity between the UM group and OM the group, either 
(Table 9).  
In general, 54.3 % of the patients who had had severe pain (VAS>50) at one-
week follow-up also reported chronic pain during different activities at 6-month 
follow-up. However, 41.8 % of those who had not reported severe pain at one-
week follow-up had pain during different activities at 6-month follow-up 
(P=0.169).  
Using logistic regression, we found that after adjusting for sex, age group 
(age <65 vs ≥65 years) and severe preoperative pain (VAS>50 vs. VAS≤50), 
type of mesh had no independent relationship (P=0.254) with chronic pain at 6-
month follow-up. The analysis revealed that the rate of chronic pain was higher 
for younger patients (OR 3.83; 95 % CI 1.71, 8.59; P=0.001) and for patients 
with severe preoperative pain (OR 2.69; 95 % CI 1.16, 6.21; P=0.021). At the 
same time, sex did not affect the primary endpoint (P=0.424). 
Of the patients, 11.9 % in the UM group and 1.5 % in the OM group had pain 
in the inguinal region, which influenced their everyday activities (P=0.018).  
None of the patients used analgesics at 6-month follow-up.  
The feeling of a foreign body in the inguinal region was experienced by 47.8 
% of the patients in the UM group and by 31.3 % of the patients in the OM 
group at 6-month follow-up (P=0.052). The risk ratio for foreign body feeling 
was 1.52 (95 % CI 1.00, 2.37). Of the patients, 59.4 % in the UM group who 
reported foreign body feeling at 6-month follow-up also had pain during 
different activities. At the same time, 34.3 % of the patients in the UM group 
who had no foreign body feeling at 6-month follow-up reported pain during 
different activities (P=0.040). In the OM group, the respective results were  
57.1 and 23.9 % (P=0.008). Comparison of these data for the two study groups 
revealed no significant difference. 
There were no significant differences in any dimension of quality of life 





















































 study III) 





















































Mean age (years) ±SD 57.4±15.0 60.7±13.8 
Age ranges (years) 18–79 19–85 
Sex ratio M:F 55:12 (82.1:17.8 %) 64:3 (95.5:4.5 %) 
BMI (kg/m²) 26.3 (18.6–35.6)ª 25.3 (19.3–33.4)ª 
Time from hernia occurrence 
to operation (months) 






23 (34.3 %) 
40 (59.7 %) 
4 (6 %) 
 
23 (34.3 %) 
38 (56.7 %) 
6 (9 %) 





11 (16.4 %) 
45 (67.2 %) 
11 (16.4 %) 
 
15 (22.4 %) 
38 (56.7 %) 






1 (1.5 %) 
66 (98.5 %) 
0 
 
6 (9 %) 
52 (77.6 %) 
9 (13.4 %) 





46 (68.7 %) 
21 (31.3 %) 
 
45 (67.2 %) 
22 (32.8 %) 
 
ª Minimal and maximal values are shown in the parentheses 














Table 8. Positive answers to the pain questionnaire at 6-month follow-up after inguinal 








Primary endpoint** 31 (46.3 %) 23 (34.3 %) 0.165 
Pain in the groin at rest 7 (10.5 %) 3 (4.5 %) 0.210 
Pain in the groin on 
coughing 
3 (4.5 %) 3 (4.5 %) 0.999 
Pain in the groin when 
rising from lying to sitting 
5 (7.5 %) 4 (6 %) 0.746 
Pain in the groin during 
physical activity 
29 (43.3 %) 21 (31.3 %) 0.159 
 
* Fisher’s exact test 
** The rate of chronic groin pain at 6-month follow-up, taking into account all patients 
who reported pain during different activities 





Figure 10. The mean visual analogue scale scores and 95 % CI based on the highest 
score for different activities before and after operation (linear mixed model) (pore size 
study III) 
VAS visual analogue scale, UM Ultrapro mesh, OM Optilene LP mesh 
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Table 9. Distribution of pain severity based on the highest pain score on the visual 














14 (20.9 %) 
3 (4.5 %) 
31 (46.3 %) 
19 (28.4 %) 
 
18 (26.9 %) 
2 (3 %) 
30 (44.8 %) 










7 (10.5 %) 
2 (3 %) 
38 (56.7 %) 
20 (29.9 %) 
 
 
13 (19.4 %) 
5 (7.5 %) 
34 (50.8 %) 











32 (47.8 %) 
3 (4.5 %) 
27 (40.3 %) 
5 (7.5 %) 
 
 
39 (54.9 %) 
8 (11.9 %) 
16 (23.9 %) 











36 (53.7 %) 
9 (13.4 %) 
18 (26.9 %) 
4 (6 %) 
 
 
44 (65.7 %) 
5 (7.5 %) 
16 (23.9 %) 




* Fisher’s exact test 
















































































































































































































































































































































































































































































































































































































































































































































5.3. Self-gripping versus sutured mesh (IV) 
The study flow-chart is presented on Figure 11.  
The patient and operative data are presented in Table 11.  
According to the primary endpoint, 45.3 % of the patients in the OLP group 
and 31.4 % of the patients in the PPG group experienced pain during different 
activities at 6-month follow-up (P=0.092). The risk ratio for the primary 
endpoint is 1.44, 95 % CI 0.82, 2.59 (P=0.184). 
Positive responses to the pain questionnaire at 6-month follow-up are pre-
sented in Table 12. Differences in the VAS scores for the study groups were 
statistically insignificant (P=0.350). Mean VAS scores and 95 % CI, based on 
the highest VAS score for different activities before operation, and at 1-week, 
1-month and 6-month follow-up, are presented in Figure 12. There were no 
statistically significant differences in the distribution of pain severity between 
the two study groups (Table 13).  
In logistic regression analysis, adjusting for the age groups (age <65 vs ≥65 
years), severe preoperative pain (VAS ≤50 vs. VAS>50) and severe early post-
operative pain (VAS≤50 vs VAS>50 at 1-week follow-up), type of mesh was 
not associated with chronic pain at 6-month follow-up (P=0.099). The analysis 
demonstrated an increased rate of chronic pain for patients with severe early 
postoperative pain (OR 4.22; 95 % CI 1.85, 9.58; P=0.001).  
At 6-month follow-up, 8 % of the patients in the OLP group and 4.3 % of the 
patients in the PPG group had pain at the operation site, which influenced their 
everyday activities (P=0.496).  
At 6-month follow-up, 5.3 % of the patients in the OLP group and 1.4 % of 
the patients in the PPG group used analgesics (P=0.368). Of the analgesic users 
at 6-month follow-up, one patient used paracetamol and four patients used 
NSAIDs.  
Overall, 22.7 %  in the OLP group and 40 % in the PPG group reported 
foreign body feeling at the operation site at 6-month follow-up (P=0.031). The 
risk ratio for foreign body feeling was 0.57, 95 % CI 0.29, 1.07 (P=0.073). Of 
the patients 76.5 % in the OLP group who experienced foreign body feeling at 
6-month follow-up also had pain during different activities. At the same time, 
36.2 % of the patients in the OLP group who had no foreign body feeling 
reported pain during different activities (P=0.005). In the PPG group, the 
respective results were 39.3 % and 26.2 % (P=0.298). 
There were no significant differences in any domain of quality of life ac-
cording to the SF36 questionnaire between the two study groups at 6-month 
follow-up, except for the social functioning domain (P=0.035). In the OLP 
group the quality of life scores improved significantly after operation in all 
domains except for general health and mental health. In the PPG group the 
quality of life scores improved significantly after operation in the domains of 
bodily pain, physical functioning and physical role (Table 14).  

























































































Mean age (years) ±SD 54.4±17.3 57.9±17.4 
Age ranges (years) 19–84 20–81 
Sex ratio M:F 68:7 (90.7:9.3 %) 65:5 (92.9:7.1 %) 
BMI (kg/m²) 25.1 (16.6–34.7)ª 25.0 (17.4–38.1)ª 
Median time from hernia 
occurrence to operation 
(months) 






20 (26.7 %) 
52 (69.3 %) 
3 (4 %) 
 
21 (30 %) 
46 (65.7 %) 
3 (4.3 %) 





23 (30.7 %) 
39 (52 %) 
13 (17.3 %) 
 
15 (21.4 %) 
46 (65.7 %) 







8 (10.7 %) 
65 (86.7 %) 
2 (2.7 %) 
0 
 
5 (7.1 %) 
62 (88.6 %) 
2 (2.9 %) 
1 (1.4 %) 
Mean operating time 
(min)* 





51 (68 %) 
24 (32 %) 
 
47 (67.1 %) 
23 (32.9 %) 
 
ª Minimal and maximal values are shown in the parentheses 
*P<0.001 (Mann-Whitney U test) 















Table 12. Positive answers to the pain questionnaire at 6-month follow-up after inguinal 
hernioplasty (self-gripping versus sutured mesh IV) 
 







34 (45.3%) 22 (31.4 %) 0.092 
Pain in the groin 
at rest 
4 (5.3 %) 6 (8.6 %) 0.523 
Pain in the groin 
on coughing 
8 (10.7 %) 1 (1.43 %) 0.034 
Pain in the groin 
when rising from 
lying to sitting 
9 (12 %) 3 (4.3 %) 0.132 
Pain in the groin 
during physical 
activity 
31 (41.3 %) 21 (30 %) 0.170 
 
*Fisher’s exact test 
**The rate of chronic groin pain at 6-month follow-up, taking into account all patients 
who reported pain during different activities 
OLP Optilene LP mesh, PPG Parietex ProGrip mesh 
 
 
Figure 12. The mean visual analogue scale scores and 95 % CI based on the highest 
score for different activities before and after operation (linear mixed model) (self-
gripping versus sutured mesh IV) 
VAS visual analogue scale, OLP Optilene LP mesh, PPG Parietex ProGrip mesh 
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Table 13. Distribution of pain severity based on the highest pain score on the visual 














14 (18.7 %) 
2 (2.7 %) 
35 (46.7 %) 
24 (32 %) 
 
24 (34.3 %) 
4 (5.7 %) 
26 (37.1 %) 










17 (22.7 %) 
3 (4 %) 
34 (45.3 %) 
21 (28 %) 
 
 
11 (15.7 %) 
3 (4.3 %) 
37 (52.9 %) 










39 (52 %) 
6 (8 %) 
22 (29.3 %) 
8 (10.7 %) 
 
 
35 (50 %) 
4 (5.7 %) 
25 (35.7 %) 










41 (54.7 %) 
5 (6.7 %) 
24 (32 %) 
5 (6.7 %) 
 
 
48 (68.6 %) 
3 (4.3 %) 
14 (20 %) 
5 (7.1 %) 
0.314 
 
*Fisher’s exact test 























































































































































































































































































































































































































































































































































































































































































































































































Recent evolution in hernia surgery and the usage of meshes has resulted in 
acceptably low recurrence rates. However, search for an ideal prosthetic mesh, 
associated with reduced chronic pain, requires extensive further research. As 
more than 160 different meshes for hernia repair are in the market [Coda et al., 
2012], it is plausible that we do not yet know the parameters of an ideal mesh. 
Because inguinal hernia repair is performed very frequently any morbidity 
associated with surgery can result in significant human, economic and societal 
burdens [van Hanswijck de Jonge et al., 2008].  
The aim of our studies was to determine whether the theoretical advantage of 
using lightweight meshes, meshes with larger pores and self-gripping meshes in 
inguinal hernioplasty would result in reduced rate of chronic groin pain and 
foreign body feeling.  
 
The International Association for the Study of Pain has defined chronic pain as 
the pain lasting longer than 3 months [Merskey and Bogduk, 1994]. Con-
sidering the use of synthetic meshes for hernia repair and taking into account 
the fact that inflammatory response to foreign material may last longer [Aas-
vang and Kehlet, 2005], we defined chronic pain as the pain lasting 6 months 
after operation. Unfortunately, the definition of chronic pain and the methology 
of its evaluation are highly variable among different publications. Therefore, 
also the rate of chronic pain varies significantly in different studies, which 
makes comparison of trials difficult.  
In a study of O’Dwyer et al. the rate of chronic pain at 1-year follow-up was 
39.5 % in the LW group and 51.6 % in the HW group (P=0.033) [O'Dwyer et 
al., 2005]. The results of our studies were similar. In our studies the rate of 
chronic pain at 6-month follow-up varied from 31.4 % (Pore size study PPG 
group) to 59.4 % (Lightweight versus heavyweight mesh HW group). However, 
Smietanski et al. demonstrated much lower rates of chronic pain 6-months after 
inguinal hernioplasty in 10.7 % of the patients in the LW group and in 9.9 % of 
the patients in the HW group [Smietanski, 2008]. Although the above trial did 
not indicate whether the pain was evaluated at rest or during physical activity, it 
is obvious that the rate of pain is different in these two situations. In our studies 
we noted low rates of chronic pain at rest at 6-month follow-up (0–10.5 %), but 
the rate of pain was much higher in all our studies during physical activities (up 
to 43.3 %). Likewise, Bringman et al. reported lower rates of chronic pain at 
rest (LW group 6.4 %, HW group 7.4 %) than during physical activities at 3-
year follow-up (LW group, 17.9 %; HW group, 23 %) [Bringman et al., 2006]. 
Unfortunately, in the same study of Bringman et al. it remains unclear whether 
the reported rates of chronic pain  at 1-year follow-up (LW group, 10.3 %; HW 
group, 12.2 %) are general pain rates, rates of pain at rest or during physical 
activities [Bringman et al., 2005].  
In our studies, all patients who reported pain during different activities 
(VAS>0) were considered as patients with chronic pain. In another study of 
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Smietanski et al. VAS> 2 (on a scale ranging from 0 to 5) was defined as 
chronic pain, resulting in a rate of chronic pain of 11.1 % [Śmietański et al., 
2009]. If chronic pain had been defined as in our studies, its rate would have 
increased to 21.2 %. In a study of Jorgensen et al., comparing self-gripping and 
sutured mesh, pain was defined as a VAS score exceeding 30 mm (on a scale 
ranging from 0 to 100), which resulted in lower rates of chronic pain (self-
gripping mesh group, 9.9 %; sutured mesh group, 7.7 %) [Jorgensen et al., 
2013]. Also in an observational study of self-gripping mesh chronic pain was 
defined as a VAS score exceeding 3, but the range of the scale remained unclear 
[Garcia Urena et al., 2011]. In comparison, in our study comparing self-gripping 
and sutured mesh the rates of chronic pain at 6-month follow-up were 31.4 % 
and 45.3 %, respectively. If we had excluded patients with mild pain (VAS 
scores 1–10), the rates of chronic pain would had remained still higher than in a 
study of Jorgensen et al. [Jorgensen et al., 2013]. As in our studies the distri-
bution of pain severity was determined using the grading system after Page et 
al. [Page et al., 2002], it is not possible to compare the results with those of 
Jorgensen et al. However, variation in the definition of chronic pain and its 
measurement may lead to underestimation of patients with chronic pain. 
 
According to the European Hernia Society guidelines on treatment of inguinal 
hernia in adult patients, the risk factors for development of chronic pain are 
preoperative pain and severe early postoperative pain. It has also been found, 
that the risk of chronic pain after hernia surgery decreases with age [Simons et 
al., 2009].  
Younger age was a risk factor for development of chronic pain also in other 
studies [Bay-Nielsen et al., 2001b; Poobalan et al., 2001] and in a systematic 
review of Nienhuijs et al. [Nienhuijs et al., 2007]. Among our studies younger 
age was a significant risk factor only in the pore size study.  
Poolaban et al. and Wright et. al have reported that preoperative pain in-
creases the risk for development of chronic pain [Poobalan et al., 2001; Wright 
et al., 2002]. As most of the patients in our studies had pain preoperatively, we 
decided to evaluate whether severe preoperative pain (VAS>50) is a risk factor 
for development of chronic pain. The analysis revealed that in the study 
comparing the weight of the meshes the only statistically significant risk factor 
at 3-year follow-up was preoperative severe pain. Also in the pore size study 
severe preoperative pain was a risk factor for development of chronic pain.  
Similarly to a study of Callesen et al. [Callesen et al., 1999], the analysis of 
our study comparing self-gripping mesh and sutured mesh demonstrated in-
creased rate of chronic pain in patients with severe early postoperative pain. In 
our lightweight versus heavyweight mesh study there was also a trend towards 
more patients having chronic pain among those who had severe pain on the 7th 




It has been shown that the amount of the material and the structure of mesh 
influence significantly scar tissue formation and chronic inflammatory reaction. 
According to Klinge et al., reduced amount of polypropylene showed pro-
nounced reduction in inflammation and improved integration into the sur-
rounding tissue [Klinge et al., 1999]. Consequently, implantig LW mesh will 
presumably diminish chronic pain and foreign body feeling.  
However, O’Dwyer et al. [O'Dwyer et al., 2005] reported higher recurrence 
rates in the LW group at 12-month follow-up compared with the HW group (5.6 
versus 0.7 %, P=0.037). The authors speculated that the reason for the higher 
recurrence rate in the LW group was not associated with mesh but with 
technical error during operation. Although the recurrence rate in the HW group 
was low, one must keep in mind that the follow-up period was only one year 
and the recurrence rate may increase over time as shown in another study by 
Bringman et al. [Bringman et al., 2006]. These authors found no significant 
difference in the recurrence rates between the HW group and the LW group, 
however, the recurrence rates had almost doubled by the time of 3-year follow-
up compared with one-year follow-up. Our study confirms a similar trend: there 
was no recurrence at 6-month follow-up while the recurrence rate was 1.7 % at 
three-year follow up, whereby there was no difference in the recurrence rates 
between the LW and HW groups.  
 
In several studies the authors concluded that use of lightweight meshes would 
reduce the rate of chronic pain [Bringman et al., 2006; O'Dwyer et al., 2005]. 
Regrettably, the meshes used in the above mentioned randomised studies 
differed not only in weight but also in pore size. This raises the question 
whether their finding (less pain in the lightweight mesh group) depended on the 
weight or the pore size of mesh. Considering this, it is evident that also other 
mesh characteristics should be explored.  
According to Weyhe et al., the size of pores rather than the amount of mesh 
is the main determinant of successful incorporation and diminished foreign 
body reaction [Weyhe et al., 2006]. Mühl et al. also found that inflammatory 
reaction largely depended on pore size [Muhl et al., 2008]. According to Klinge 
et al., mesh with large pores was integrated in a loose network of perifilamenta-
ry granulomas and the fat tissue, and mesh with small pores was embedded into 
granulomas and the scar tissue, which bridged the pores completely [Klinge et 
al., 2002b]. Our study demonstrated that the use of the mesh with larger pores 
compared with the mesh with smaller pores did not reach significance in terms 
of chronic pain. Nevertheless, although the difference was statistically insigni-
ficant, there were more patients reporting pain in the group where the mesh with 
larger pores was used. The meshes used in the pore size study had different 
composition at implantation. Interestingly, when in a study of Orenstein et al. 
the mesh consisting of polypropylene and polyglactin induced a significant 
chronic inflammatory response [Orenstein et al., 2012], then in a study of 
Klinge et al. the inflammatory response of the mesh of polypropylene combined 
with polyglactin was considerably reduced compared to other polypropylene 
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meshes [Klinge et al., 1999]. One explanation could certainly be that 
Oreinstein’s study was an experimental study on mice while the study of Klinge 
et al. involved removal of meshes during revision operations. Another expla-
nation could be that the study of Klinge et al. explored Vypro® mesh and and 
the study of Orenstein et al. used Ultrapro® mesh. Although both meshes are 
made of polypropylene with an addition of polyglactin, Vypro® mesh is a 
multifilament mesh [Post et al., 2004] and Ultrapro® mesh is a monofilament 
mesh [Bury and Smietanski, 2012]. Monofilament and multifilament meshes 
have been studied in terms of infection [Klinge et al., 2002a] but not in terms of 
chronic pain. However, as polyglactin, one component of Ultrapro® mesh, was 
already absorbed at 6-month follow-up [Klosterhalfen et al., 2005], it is there-
fore unlikely that the different composition of the meshes is the reason for the 
above mentioned trend.  
 
The suture fixation of a mesh has been postulated to impact development of 
chronic groin pain after inguinal hernia surgery. To exclude suture fixation as 
the cause of chronic pain and to reduce the rate of chronic pain, alternative 
fixation methods, such as tissue glue and self-gripping meshes, have been 
developed.  
Kingsnorth et al. have reported potential benefits of self-gripping mesh com-
pared with sutured mesh [Kingsnorth et al., 2012]. Also other studies have 
demonstrated promising results for self-gripping meshes in terms of chronic 
pain [Quyn et al., 2012]. In a study of Kingsnorth et al. the change in VAS 
scores compared to baseline was significantly different  between the self-
gripping and sutured mesh groups only at early postoperative visits, but not at 3 
months; nor was the rate of chronic pain significantly different between the 
study groups at 3-month follow-up [Kingsnorth et al., 2012]. Also, considering 
our definition of chronic pain (6 months postoperatively), further results from 
the Kingsnorth’s study would be needed. Kingsnorth et al. performed also 
subgroup analysis. In the self-gripping mesh group a single stitch over the pubic 
bone was used in 25.5 % of the patients; at 3-month follow-up the VAS scores 
were significantly more reduced compared with baseline in the subgroup where 
no fixation was used. This indicates the importance of sutures in development 
of postoperative pain. Another study whose results would favour the use of self-
gripping mesh is a study of Quyn et al. where the rate of chronic pain at 6-
month follow-up was 7.9 % in the self-gripping mesh group and 21 % in the 
sutured mesh group. The respective results at 1-year follow-up were 6.3 % and 
18.8 % [Quyn et al., 2012]. Unfortunately, as that study was not a randomised 
study its level of evidence is lower.  
At the same time, in several studies the use of a self-gripping mesh did not 
result in decreased rate of chronic symptoms [Jorgensen et al., 2013; Pierides et 
al., 2012]. Definitely, one strength of the study of Pierides et al.  is the fact that 
they recorded patients’ type of work (sedentary versus physical); yet they did 
not perform subgroup analysis in order to evaluate the association of chronic 
pain with character of everyday work [Pierides et al., 2012]. In a study of 
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Jorgensen et al. the primary aim was to address moderate or severe pain and/or 
numbness and/or discomfort at 1-year follow-up. The reason for using a 
composite endpoint was to make more powerful statistical assessment, because 
each complication occurs infrequently. Moderate to severe symptoms occurred 
in 17.4 % of the patients in the self-gripping mesh group and in 20.2 % in the 
sutured mesh group (P=0.573) [Jorgensen et al., 2013]. Although in the study of 
Pierides et al. there was no difference between the two study groups either, the 
reported rate of chronic symptoms was much higher (36.3 % in the self-gripping 
mesh group,  34.1 % in the sutured mesh group) than in the study of Jorgensen 
et al. One reason for this could be that Pierides et al. included all patients with 
complaints, unlike the study of Jorgensen et al. where patients with mild symp-
toms were excluded from the analysis of the primary endpoint [Jorgensen et al., 
2013; Pierides et al., 2012]. Similarly to Pierides et al., we included all patients 
who reported pain (VAS>0) in evaluation of the primary endpoint. In a study of 
Chastan only 1 of 52 patients reported pain at 1-year follow-up [Chastan, 2009]. 
The reason how Chastan achieved such a low pain rate remains unclear. 
However, Chastan’s study was not randomised and another limitation of that 
study is that it included not only primary unilateral hernias as most studies do 
but also recurrent hernias and bilateral hernias [Chastan, 2009]. In a prospective 
study of Pedano et al., evaluating the results of usage of self-gripping mesh, the 
rate of chronic pain was also only 4 % at a median follow-up of 17 months. 
Again, it should be stressed that only patients who had invalidate pain were 
included in assessment of chronic pain. Unfortunately, the definition of 
invalidate pain was not specified [Pedano et al., 2012].  
According to previous systematic reviews and meta-analyses, self-gripping 
mesh has been associated with shorter operating time (15–17). Li et al. sug-
gested that reduced operating times with shorter exposure times of the mesh 
may result in decreased rate of wound infections [Li et al., 2014]. Also in our 
study of self-gripping versus sutured mesh, the operating time was 10 minutes 
shorter in the PPG group. However, considering the fact that the rate of wound 
infection was exceedingly low (1 case in the PPG group at 1-month follow-up), 
we cannot make any conclusion about it. In a study of Kapischke et al. the mean 
operating time was 12.2 minutes shorter in the self-gripping mesh group than in 
the sutured mesh group and the authors speculate that the increased costs of 
self-gripping meshes are compensated for by the reduced utilization of the 
operating room [Kapischke et al., 2010] Evidently, analysis of cost-effective-
ness would be useful to evaluate the benefit of shorter operating time and the 
usage of more expensive mesh compared to standard mesh. 
 
Significantly less patients in our study experienced pain during different 
activities at three-year follow-up in the LW group as well as in the HW group 
compared with the results of 6-month follow-up. This finding is important in 
management of postoperative chronic pain following inguinal hernia surgery. 
International guidelines recommend to resort to surgical treatment not earlier 
than 1 year after operation when the inflammatory response has decreased 
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[Alfieri et al., 2011]. Unfortunately, we had not planned follow-up at 1 year, but 
we can speculate that, considering the high rate of chronic pain at 6-month 
follow-up, the rate of chronic pain would have been high also at 1 year. Also in 
a population-based cohort study of Kalliomäki et al. less than three years from 
operation was associated with an increased risk for chronic pain [Kalliomaki et 
al., 2008]. Therefore, it might be necessary to postpone surgical treatment even 
more than one year after primary operation.  
 
Foreign body feeling after inguinal hernia repair has not gained as much 
attention as chronic pain. Although according to Smietanski et al., the clinical 
relevance of foreign body feeling is unknown and it might not influence daily 
activities [Smietanski et al., 2012], patients report it often. Considering that 
Bringman et al. have stated that a successful procedure is one in which a patient 
has no sensation of foreign body and can return quickly to normal activities 
[Bringman et al., 2010], they seem to disagree with the opinion of Smietanski et 
al.  opinion about the relevance of foreign body feeling.  
In a study of Post et al., which is one of the few studies where foreign body 
feeling is the primary outcome measure, more patients had the feeling of a 
foreign body after hernia repair at 6-month follow-up with HW mesh compared 
with LW mesh (43.8 vs. 17.2 %, P=0.003). Our study comparing meshes with 
different weights revealed a similar trend (32.8 versus 20.9 %) but the 
difference was statistically insignificant. As the lightweight versus heavyweight 
mesh study presented also 3-year follow-up results, it was possible to evaluate 
the time factor in occurrence of chronic symptoms. While the time factor was 
important in reducing the rate of chronic pain, the rate of foreign body feeling 
remained immutable. At 6-month follow-up 32.8 % of the patients in the HW 
group and 20.9 % of the patients in the LW group experienced foreign body 
feeling; at 3-year follow-up the respective results were 27.6 % and 20.7 %. 
Interestingly, although the rate of chronic pain had reduced significantly by the 
time of 3-year follow-up, the rate of foreign body feeling had not diminished. 
However, in a study of Paajanen et al., comparing three meshes with different 
weights, foreign body feeling was more common at 1-year follow-up than at 2- 
or 5-year follow-up [Paajanen, 2007; Paajanen et al., 2013].  
In the pore size study the results of foreign body feeling were unexpected. 
Surprisingly, mesh with larger pores even revealed a trend of higher rate of 
foreign body feeling. The reason why more patients experienced foreign body 
feeling in the study group where mesh with larger pores was used is unclear. 
We speculate that one explanation could be the unequal distribution of female 
patients between the two study groups. According to a meta-analysis, women 
respond more readily with pain to a stimulus that men may report as not painful 
[Riley III et al., 1998]. Therefore, considering also the fact that there was corre-
lation between chronic pain and foreign body feeling, the trend towards higher 
rate of foreign body feeling in the UM group with more female patients would 
be explainable. Yet logistic regression did not confirm our speculation: sex did 
not affect the primary endpoint. Another explanation could lie in the different 
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composition of the meshes (Ultrapro® consists of polypropylene and poly-
glecaprone and Optilene® LP consists of polypropylene). However, taking into 
account that the absorbable component of Ultrapro, polyglecaprone, is fully 
absorbed during 84–140 days [Klosterhalfen et al., 2005], the meshes will have 
a similar composition at 6-month follow-up. In an experimental study by Oren-
stein et al. Ultrapro mesh, which is a lightweight macroporous material, caused 
a surprisingly strong chronic inflammatory response [Orenstein et al., 2012]. 
Although similar results with Optilene LP mesh are not available, the finding of 
Orenstein et al. might also account for the higher rate of foreign body feeling in 
the UM group in our study.  
Also the results of our study comparing self-gripping mesh and sutured mesh 
in terms of foreign body feeling were surprising. The rate of foreign body 
feeling was higher in the study group where self-gripping mesh was used. It 
should be noted that as Parietex ProGrip™ mesh has microgrips across its 
surface area, the resorption time of which is 12 months [Chastan, 2009], this 
might account for the higher rate of foreign body feeling in the PPG group at 6-
month follow-up. Therefore, we planned another follow-up three years after 
operation. 
 
Although the rates of chronic pain in our studies were high, we noted a signifi-
cant improvement in the quality of life scores after surgery compared with 
preoperative scores in most domains of the lightweight versus heavyweight 
mesh study and in the pore size study. Also in a study of Bringman et al. com-
paring the weight of meshes there was no difference between the study groups, 
but the quality of life scores improved postoperatively [Bringman et al., 2005]. 
Interestingly, when quality of life was evaluated in several studies com-
paring the weight of different meshes [Bringman et al., 2005; Post et al., 2004; 
Smietanski, 2008], then it seems that interest in evaluating quality of life has 
been lost in studies comparing self-gripping and sutured meshes, except in a 
study of Jorgensen et al. where SF12 was used [Jorgensen et al., 2013]. In our 
study comparing self-gripping mesh and sutured mesh only the scores which 
describe pain and physical health, i.e. bodily pain, physical functioning and 
physical role, improved in both study groups. Smietanski et al. had similar 
results in a study comparing the weight of meshes, except that in their study 
also the role emotional domain improved significantly in both study groups 
[Smietanski, 2008]. In a study of Post et al., besides improvement in scores of 
the domains associated with pain and physical health, there improved, 
additionally, the domain of social functioning [Post et al., 2004]. Surprisingly, 
in the ANCOVA analysis of our study comparing self-gripping mesh and 
sutured mesh, the type of mesh influenced the quality of life scores in the 
domain of social functioning. The reason why the type of mesh influenced only 
one domain are unclear. Taking account of the fact that this domain can be in-
fluenced by many factors, it is unlikely that the type of mesh had actually a 
significant effect on this result.  
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Considering the variability in results, there raises the question about whether 
it is necessary to evaluate the full range of SF36 or RAND SF36 or only the 
domains describing bodily pain and physical health. Although several studies on 
the same topic have used a modification of SF36 [Yazdankhah Kenary et al., 
2013], further research is needed to find out an optimal questionnaire to 
evaluate the outcome of hernia surgery.  
Still, improvement in most quality of life scores after inguinal hernia surgery 
indicates the importance of prompt elective repair of symptomatic inguinal 
hernias that could significantly restrict patients’ physical activities without ope-
ration. It also demonstrates that inguinal hernias have a greater influence on the 
quality of life than is generally thought. 
 
The high rate of chronic pain in our studies as well as in several other studies 
[O'Dwyer et al., 2005; Śmietański et al., 2009] raises the question about the 
surgical treatment of asymptomatic inguinal hernias. According to the EHS 
guidelines on the treatment of inguinal hernia, watchful waiting is an acceptable 
option in the case of asymptomatic inguinal hernias; in particular, it should be 
considered for older patients and for patients with major comorbidities [Miserez 
et al., 2014]. In a study of Fitzgibbons et al. 23 % of the patients had crossed 
over from the watchful waiting group to the surgical treatment group after 2 
years, mostly because of the increase of hernia related pain [Fitzgibbons et al., 
2006]. In a study of Chung et al. 72 % of the patients initially randomized to the 
observation group underwent conversion to operation at 7.5 years [Chung et al., 
2011]. In a study of Kalliomäki et al. 34 % of the patients were pain-free before 
the operation and of these 21 % reported having pain at follow-up [Kalliomaki 
et al., 2008]. However, considering the low risk of incarceration of 0.3–3 % per 
year [Simons et al., 2009] and the risk for development of chronic postoperative 
pain, whose rate in our studies reached 59.4 % at 6-month follow-up, inguinal 
hernia repair should probably be postponed in asymptomatic cases until there 
develop complaints. 
 
A limitation of our studies could be that we did not record if the nerves in the 
inguinal canal were sacrificed and hence we cannot make any conclusions about 
nerve damage and chronic pain. Another limitation might be related to the study 
comparing self-gripping mesh and sutured mesh: the material of the sutured 
mesh used in that study was polypropylene and the material of the self-gripping 
mesh was polyester. Still, in some studies, polypropylene and polyester meshes 
yielded similar results in terms of chronic pain [Sadowski et al., 2011]. On the 
other hand, in experimental studies polyester meshes induced more chronic 
inflammation and marked foreign body reaction [Orenstein et al., 2012]. 
Although in a study of Klinge et al. polyester mesh and polypropylene mesh 
with reduced weight resulted different thicknesses of collagen capsules around 
the mesh fibres, the inflammatory infiltrate was similar in both cases [Klinge et 
al., 1999].  
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In order to improve the results of inguinal hernia repair and to reduce the rate of 
chronic pain, further research is definitely needed. Considering that usage of 
meshes has significantly reduced recurrence rates, it is evident that meshes will 
remain in use for a longer period of time. Consequently, further research to 
develop meshes with optimal parameters is of vital importance and should be 
encouraged.  
One drawback of published studies is the lack of consensus on definition of 
chronic pain, which makes it complicated to compare the results of different 
studies and to conduct meta-analyses and systematic reviews. Therefore, a 
uniform definition of chronic pain and its best assessment methods should be 
developed in order to conduct top quality multicentre randomised trials.  
Most published studies on inguinal hernia repair comparing different meshes 
have presented short- or mid-term results. However, longer follow-up of , e. g. 5 
and 10 years, would be useful in order to evaluate the rate of chronic pain and 
its impact on quality of life.  
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7. CONCLUSIONS 
1. According to our studies, the weight, pore size and suture fixation of a mesh 
have not a significant influence on development of chronic pain. However, 
other mesh parameters,  particularly, their combinations should be explored. 
2. Considering the high rate of early severe postoperative pain (papers III and 
IV) and the association between early severe pain and development of chro-
nic pain (paper IV), a better postoperative pain control strategy is needed. 
3. Significantly less patients experienced pain during different activities at 
three-year follow-up compared with the results of 6-month follow-up (papers 
I and II). Therefore, if surgical treatment of chronic pain is considered, it 
should be postponed for more than one year after primary operation.  
4. Considering the high rate of chronic postoperative pain in asymptomatic 
cases, postponement of hernia repair until possible development of com-
plaints should be considered.  
5. Improvement in quality of life scores after inguinal hernia surgery indicates 
the importance of prompt elective repair of symptomatic inguinal hernias 
and demonstrates that inguinal hernias have a greater influence on quality of 
life than is generally thought. 
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8. SUMMARY IN ESTONIAN 
Alloplastika võrkude mõju kroonilise valu ja 
võõrkehatunde tekkimisele kubemesonga ravis 
8.1. Sissejuhatus 
Viimastel aastakümnetel on palju diskuteeritud kubemesongade etioloogia, 
kirurgilise ravi näidustuste, kirurgilise ravimeetodi valiku, erinevate võrkude 
kasutamise, songaretsidiivide ja krooniliste herniotoomiajärgsete sümptomite 
üle.  
Kuigi kõige enam levinud võrgumaterjal polüpropüleen avastati 60 aastat ta-
gasi ja turul pakutakse üle 160 erineva võrgu [Coda et al., 2012], ei ole ideaalse 
võrgu omadused ikkagi teada [Simons et al., 2009].  
Peale alloplastika võidukäiku songade ravis on sagedaseks probleemiks 
muutunud krooniline valu, mida esineb kubemesonga plastika järgselt kuni  
51,6 % patsientidest [O'Dwyer et al., 2005]. Võõrkehatunne esineb ingvinaal-
herniotoomia järgselt kuni 43,8 % patsientidest [Post et al., 2004].  
Arvestades kroonilise valu ja võõrkehatunde sagedast esinemist kubeme-
songa plastika järgselt, mis võivad oluliselt halvendada patsientide elukvaliteeti, 
on kindlasti vajalik võrgu erinevate omaduste uurimine, et leida võrk, mille 
kasutamisel esineks kroonilisi sümptomeid vähem. 
 
 
8.2. Uuringu eesmärgid 
1.  Hinnata kroonilise valu esinemist erinevate võrkude kasutamisel ja selgitada, 
millised võrgu  parameetrid omavad olulist mõju kroonilise valu tekkimisele 
ingvinaalherniotoomia järgselt. 
2.  Hinnata võõrkehatunde esinemist erinevate võrkude kasutamisel ja selgitada, 
millised võrgu parameetrid omavad olulist mõju võõrkehatunde tekkimisele 
ingvinaalherniotoomia järgselt. 
3.  Hinnata patsientide elukvaliteeti ingvinaalherniotoomia järgselt. 
 
 
8.3. Uuritavad ja meetodid 
Uuringusse kaasati Tartu Ülikooli Kliinikumi Kirurgiakliiniku üldkirurgia ja 
plastikakirurgia osakonnas opereeritavad vähemalt 18-aastased patsiendid, 
kellel oli ühepoolne reponeeritav kubemesong ning kes andsid nõudoleku uurin-
gus osalemiseks. Uuringusse ei kaasatud alla 18-aastaseid patsiente ega mitte-
reponeeritava songaga, pitsunud songaga ja retsidiivsongaga patsiente. Uurin-
gusse ei kaasatud ka neid patsiente, kes ei olnud võimelised küsimustikust aru 
saama või ei soovinud uuringus osaleda.  
Patsiendid randomiseeriti ühte kahest uuringugrupist. 
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Esimeses uuringuetapis võrreldi kahte erineva kaaluga monofilamentset 
polüpropüleen-võrku. Raske võrgu grupis kasutati Premilene® võrku (B. Braun 
Melsungen AG, Melsungen, Germany), mille kaal on 82 g/m² ja poori suurus on 
0,8 mm. Kergvõrgu grupis kasutati Optilene®LP võrku (B. Braun), mille kaal 
on 36 g/m² ja poori suurus on 1 mm.  
Teises uuringuetapis võrreldi erineva poorisuurusega võrke. Uuringus kasu-
tatud suurema pooriga võrk oli Ultrapro® võrk (Ethicon, Hamburg, Germany), 
mis koosneb polüpropüleenist ja resorbeeruvast polüglekaproonist. Ultrapro® 
võrgu poori suurus on 3–4 mm ja kaal 28 g/m². Kasutatud väiksema pooriga 
võrk oli eelpool kirjeldatud Optilene®LP võrk.  
Uuringu kolmandas etapis, kus hinnati võrgu fikseerimiseks kasutatavate 
õmbluste rolli kroonilise valu tekkimisel, kasutati samuti eelpool kirjeldatud 
Optilene®LP võrku ja isetakerduvat Parietex ProGrip™ võrku (Covidien, 
Trevoux, France). Isetakerduv võrk on tehtud polüestrist ja resorbeeruvast 
polülaktikhappest. Parietex ProGrip™ võrgu kaal on 38 g/m² ja poori suurus 1,1 
x 1,7 mm ning selle pind on kaetud resorbeeruvate mikrokonksukestega, mis 
tagavad võrgu fikseerumise kudede külge.  
Kõikidele patsientidele tehti kubemesonga plastika Lichtensteini järgi. Ise-
takerduva võrgu kasutamisel olid operatsiooni etapid sarnased Lichtensteini 
plastikale, välja arvatud see, et ei kasutatud võrku fikseerivaid õmblusi.  
Uuringu esmaseks tulemusnäitajaks oli kroonilise valu esinemine 6. Post-
operatiivsel kuul. Võõrkehatunne ja elukvaliteet olid uuringu teisesed tule-
mused.  
Enne operatsiooni, 7. postoperatiivsel päeval, 30. postoperatiivsel päeval, 6. 
postoperatiivsel kuul ja esimese uuringuetapi puhul ka 3. postoperatiivsel aastal 
registreeriti valu esinemine erinevate tegevuste korral: rahuolekus, köhimisel, 
lamamisasendist tõusmisel ja füüsilisel koormusel. Valu tugevus märgiti 
visuaalanaloogskaalal (VAS) 0 (valu puudub) kuni 100 (maksimaalne valu).  
Samuti registreeriti kõikidel postoperatiivsetel järelkontrollidel võõrkeha-
tunde esinemine (jah-ei küsimus).  
Elukvaliteedi hindamiseks täideti enne operatsiooni ja 6. postoperatiivsel 
kuul elukvaliteedi küsimustik (RAND SF36 küsimustik). Antud küsimustikuga 
hinnatakse järgmisi elukvaliteedi valdkondi: üldine tervisehinnang, vitaalsus, 
kehaline valu, vaimne tervis, sotsiaalne toimetulek, füüsiline toimetulek, emot-
sionaalse seisundi probleemidest tingitud piirangud, füüsilise tervise häiretest 
tingitud piirangud.  
 
8.4. Tulemused 
Uuringu esimeses etapis, kus võrreldi erineva kaaluga võrke, esines 6. Post-
operatiivsel kuul valu  (VAS skoor ≥1) erinevate tegevuste korral raske võrgu 
grupis 59,4 % ja kergvõrgu grupis 47,8 % patsientidest (P=0,221). Vastavad 
tulemused 3. postoperatiivsel aastal olid 17,2 % ja 29,3 % (P=0,132). Võõr-
kehatunne esines 6. postoperatiivsel kuul raske võrgu grupis 32,8 % ja kerg-
võrgu grupis 20,9 % patsientidest (P=0,123) ning 3. postoperatiivsel aastal 
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vastavalt 27,6 % ja 20,7 % patsientidest (P=0.397). Elukvaliteedi skooride osas 
kahe grupi vahel statistiliselt olulisi erinevusi ei olnud. Postoperatiivselt para-
nesid mõlemas grupis oluliselt elukvaliteedi skoorid, välja arvatud üldise 
tervisehinnangu valdkonna skoorid.  
Uuringu teises etapis, kus võrreldi erineva poorisuurusega võrke, esines 6. 
Postoperatiivsel kuul valu suurema pooriga võrgu grupis 46,3 % ja väiksema 
pooriga võrgu grupis 34,3 % patsientidest (P=0,165). Võõrkehatunnet esines 6. 
postoperatiivsel kuul vastavalt 47,8 % ja 31,3 % patsientidest (P=0,052). Elu-
kvaliteedi skooride osas kahe grupi vahel statistiliselt olulisi erinevusi ei olnud. 
Postoperatiivselt paranesid mõlemas grupis oluliselt elukvaliteedi skoorid, välja 
arvatud sotsiaalse toimetuleku skoor väiksema pooriga võrgu grupis.  
Uuringu kolmandas etapis, kus võrreldi õmblustega fikseeritavat võrku ja 
isetakerduvat võrku, esines 6. postoperatiivsel kuul valu õmblustega fikseeri-
tava võrgu grupis 45,3 % ja isetakerduva võrgu grupis 31,4 % patsientidest 
(P=0,092). Võõrkehatunnet esines 6. postoperatiivsel kuul vastavalt 22,7 % ja 
40 % patsientidest (P=0,031). Elukvaliteedi skooride osas kahe grupi vahel 
statistiliselt olulisi erinevusi ei olnud, välja arvatud sotsiaalse toimetuleku skoo-
ride osas. Postoperatiivselt paranesid õmblustega fikseeritava võrgu grupis olu-
liselt elukvaliteedi skoorid, välja arvatud üldise tervisehinnangu ja vaimse 
tervise skoorid. Isetakerduva võrgu grupis paranesid oluliselt kehalise valu, 




1. Meie uuringute tulemusena ei oma võrgu kaal, poori suurus ja võrku fiksee-
rivad õmblused olulist mõju kroonilise valu tekkimisele. Kindlasti on  vaja-
lik võrkude teiste omaduste ja eelkõige võrkude erinevate omaduste kombi-
natsioonide edasine uurimine. 
2.  Arvestades varajase tugeva valu esinemist ja seost varajase tugeva valu ning 
kroonilise valu tekkimise vahel ingvinaalherniotoomia järgselt, on vajalik 
postoperatiivse valuravi parema skeemi väljatöötamine. 
3.  Kuna kolmandal postoperatiivsel aastal esines kroonilist valu oluliselt vähem 
kui 6. postoperatiivsel kuul, siis juhul kui kaalutakse kroonilise valu kirur-
gilist ravi, tuleks see võimalusel edasi lükata rohkem kui aasta peale esmast 
operatsiooni. 
4.  Arvestades kroonilise valu sagedast esinemist ingvinaalherniotoomia järg-
selt, peaks asümptomaatiliste kubemesongade puhul kirurgilist ravi edasi 
lükkama kuni sümptomite tekkimiseni.  
5.  Kuna patsientide elukvaliteet paranes oluliselt ingvinaalherniotoomia järg-
selt, siis sümptomaatilisi kubemesongasid on soovitav opereerida plaanilises 
korras esimesel võimalusel. Samuti näitab elukvaliteedi paranemine 
kubemesonga alloplastika järgselt seda, et kubemesongadel on suurem mõju 
elukvaliteedile, kui seni on üldiselt arvatud.  
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